COMPENSATION
OF EXECUTIVE OFFICERS
Compensation Discussion and Analysis
Introduction.
This
Compensation Discussion and Analysis section discusses the compensation policies and programs for our named executive officers.
2021 Company Highlights.
During 2021, our management team accomplished the following:
Acquisitions
~$886mm
warehouse/distribution
$111.5mm
invested
in ongoing
development
|
|
Dispositions
~$824mm
Recapitalized
22-property
non-core portfolio
|
|
|
|
Leasing
8.5mm
square
feet
10.9%
and 6.7%
increases
in industrial Base and
Cash Base rents
|
|
Balance Sheet
5.5x
Net
debt to adjusted EBITDA
$648mm
capital raised |
Named Executive
Officers. Our named executive officers are:
Name |
|
Title |
T. Wilson Eglin |
|
Chairman, Chief Executive Officer and President |
Beth Boulerice |
|
Executive Vice President, Chief Financial Officer and Treasurer |
Joseph S. Bonventre |
|
Executive Vice President, Chief Operating Officer, General Counsel and Secretary |
Brendan P. Mullinix |
|
Executive Vice President and Chief Investment Officer |
Lara Johnson |
|
Executive Vice President |
Compensation
Committee Responsibility and Philosophy. The Compensation Committee administers the compensation policies and programs for
our named executive officers and regularly reviews and approves our compensation strategy and principles to ensure that they are
aligned with our business strategy and objectives, encourage high performance, promote accountability and ensure that management’s
interests are aligned with the interests of our shareholders. The Compensation Committee believes that the
compensation program
should further both short-term and long-term business goals and strategies while enhancing shareholder value. In keeping with this
philosophy, the compensation program’s objectives are to:
| ● | maintain a transparent compensation program that is easy for all of our shareholders to understand; |
| ● | further align the interests of our named executive officers with those of our shareholders; |
| ● | strengthen the relationship between executive pay and company performance; and |
| ● | retain key members of management. |
The
Compensation Committee believes that the business judgment of its members is necessary to properly evaluate and design an executive
compensation program.
2021
“Say on Pay” Advisory Vote
In 2021,
approximately 99% of our shareholders (excluding broker non-votes) voted “FOR” the compensation of our named executive
officers as disclosed in the related proxy statement, which has been consistent with the votes for the previous years.
Based
on such approvals, the Compensation Committee has largely maintained the compensation framework approved in 2021 for 2022 with
modifications for our 2022 business plan objectives and our strategic alternative review.
Shareholder
Engagement
We
regularly engage with our shareholders on a variety of matters, including:
| ● | general business updates; |
| ● | our transformation initiatives; |
| ● | board composition, risk oversight and refreshment; |
| ● | corporate governance practices; |
| ● | ESG strategy (including diversity, climate change, environmental sustainability and disclosures);
and |
During
2021, we:
| ● | contacted and offered to meet with shareholders holding in excess of 63% of our common shares as
of December 31, 2021; |
| ● | scheduled meetings with shareholders holding in excess of 41% of our common shares as of December
31, 2021; and |
| ● | had one or more independent members of our Board of Trustees meet with shareholders holding 28%
of our common shares as of December 31, 2021, including two separate meetings between an independent member of our Board of Trustees
and a fund manager affiliated with FMR LLC. |
Executive
Compensation Best Practices.
The
following is a summary of our executive compensation practices:
What
we do: |
|
What
we don’t do: |
We pay for performance
We disclose our compensation programs with transparency
We assess compensation risk
We use an independent compensation consultant
We use competitor and size-based peer groups
We require hold periods and have minimum share ownership guidelines
We have a robust clawback policy |
|
We do not provide tax gross-up payments |
|
We do not have excessive severance arrangements or single-trigger change in control severance payments |
|
We do not encourage unnecessary or excessive risk taking as a result of our compensation policies |
|
We do not guarantee compensation or uncapped bonus payments |
|
We do not allow for repricing of stock options. |
|
We do not allow hedging or pledging of our stock |
|
|
Independent
Compensation Consultant
During
2021, the Compensation Committee retained Ferguson Partners Consulting, L.P., a nationally known executive compensation and benefits
consulting firm, which we refer to as FPC. Other than reviewing and advising the Compensation Committee with respect to executive
and trustee compensation, FPC does not provide any non-executive compensation or other services for us. As a result, FPC is an
independent compensation consultant. Management does not retain any executive compensation consultant.
Peer
Group Benchmarking Analysis.
We
are always competing for the best talent with our direct industry peers and with the broader market. Accordingly, the Compensation
Committee regularly reviews the market data, pay practices and ranges of our “peer” companies and the broader market
to ensure that we continue to offer a relevant and competitive executive pay program each year. Throughout this Compensation Discussion
and Analysis, we refer to two distinct peer groups, as described below, which were established by the Compensation Committee’s
independent compensation consultant, the Compensation Committee and our Chief Executive Officer in 2021.
| ● | Competitor Peer Group. For 2021, this group consisted of 12 public REITs, which are
either (1) our competitors for industrial property acquisitions and tenants in the single-tenant industrial space or (2) owners
of a portfolio of primarily net-leased assets. The companies included in this peer group are as follows: |
Broadstone Net Lease, Inc. |
EastGroup Properties, Inc. |
Essential Properties Realty Trust, Inc. |
First Industrial Realty Trust Inc. |
Getty Realty Corp. |
National Retail Properties, Inc. |
PS Business Parks, Inc. |
Rexford Industrial Realty, Inc. |
STAG Industrial, Inc. |
STORE Capital Corporation |
Terreno Realty Corporation |
W.P. Carey Inc. |
This
competitor peer group helped the Compensation Committee understand how each named executive officer’s total compensation
compares with the total compensation for reasonably similar positions at our most direct REIT competitors.
| ● | Size Peer Group. For 2021, this group consisted of 20 public REITs, which operate
across multiple asset classes and are similar in size to our total capitalization. The total capitalization range for this peer
group was $4.1 billion to $7.1 billion as of October 31, 2021. Our total capitalization was at approximately the 65th percentile
($5.7 billion) of this peer group as of October 31, 2021. The companies included in this peer group are as follows: |
Apple Hospitality
REIT, Inc.
Corporate
Office Properties Trust
Healthcare
Realty Trust Incorporated
JBG SMITH
Properties
Physicians
Realty Trust
Retail Properties
of America Inc.
SITE Centers
Corp. |
Brandywine
Realty Trust
Empire State
Realty Trust, Inc.
Innovative
Industrial Properties, Inc.
Preferred
Apartment Communities, Inc.
RLJ Lodging
Trust
Terreno
Realty Corporation |
Broadstone
Net Lease, Inc.
Essential
Properties Realty Trust, Inc.
iStar Inc.
Pebblebrook
Hotel Trust
PS Business
Parks, Inc.
Sabra Health
Care REIT, Inc.
Veris Residential, Inc. |
The
size-based peer group helped the Compensation Committee compare our overall compensation practices against a broader mix of REITs
to ensure that our compensation practices are reasonable in light of the size of our organization. The Compensation Committee generally
focuses on the average of the two peer groups, except in cases where such average is determined to be excessive in light of the
circumstances.
Although
the two peer groups are comprised solely of REITs, we also compete with other public and private companies in the New York metropolitan,
Dallas and West Palm Beach marketplaces for talent. Therefore, we also consider other information regarding market trends in compensation
in addition to the data derived from these peer group reviews.
FPC
prepared a compensation study for the Compensation Committee that contains:
| ● | A summary of market findings; |
| ● | High-level performance information and its impact on compensation trends within the real estate
industry; |
| ● | Certain background information, including size and performance statistics for our company and the
peer group constituents; and |
| ● | The results of a competitive benchmarking analysis for our named executive officers and certain
other employees on both an individual and aggregate basis. |
Determining
the Amount of Each Element of Compensation.
The
Compensation Committee reviews the performance of each of our named executive officers, including our Chief Executive Officer,
on an annual basis. The Compensation Committee considers, among other things, (1) the scope of the individual’s responsibilities,
including the demands and profile of the positions held by the individual, (2) the individual’s experience and tenure with
us, (3) the individual’s performance and contribution to our performance, (4) our performance against annual objectives set
forth in management’s business plan, and (5) competitive salaries. The Compensation Committee considers the results of compensation
studies prepared for it by FPC and by industry and trade associations.
Our
Chief Executive Officer assists in the annual review of our named executive officers and makes recommendations to the Compensation
Committee. However, the Compensation Committee makes all determinations with respect to the actual compensation of our named executive
officers, including our Chief Executive Officer.
The
independent compensation consultant provides the following services to the Compensation Committee:
| ● | Management Data Collection: |
| ○ | reviewing historical pay philosophy and practices; |
| ○ | confirming the existing compensation philosophy; and |
| ○ | reviewing the Chief Executive Officer’s recommendations. |
| ● | Compensation Guidance and Commentary: |
| ○ | providing initial thoughts and reactions to the Chief Executive Officer’s recommendations
in light of current market practices and performance; |
| ○ | providing thoughts and perspectives on the broader REIT market, from a compensation perspective,
based on ongoing conversations with executives/board members and up-to-date compensation data; and |
| ○ | providing a compensation study described above and recommendations regarding peer group data. |
Compensation
Risk Assessment
The
Compensation Committee does not believe our executive compensation programs encourage unnecessary or excessive risk taking for
the following reasons:
| ● | There are no guaranteed minimum payouts. |
| ● | The annual cash incentive opportunity does not rely on total return to shareholders. |
| ● | The annual cash incentive opportunity is based on multiple operational performance metrics. |
| ● | Net Debt to Adjusted EBITDA is the only adjusted/non-GAAP metric, but we regularly disclose this
metric, including a reconciliation, and analysts and investors use it as a balance sheet metric to compare us to our peers. |
| ● | The annual long-term incentive opportunity has a three-year performance period based on total shareholder
return relative to a competitor peer group and an index. |
While
we are focused on long-term shareholder value, the Compensation Committee believes that three-year vesting for share awards is
an appropriate length of time due to the need to retain and reward results. Furthermore, our Compensation Committee believes the
overall amount of our long-term incentive awards is relatively conservative.
We
also pay dividends currently on the time-based portion of our annual long-term incentive awards and dividends accrue on the performance-based
portion of our annual long-term incentive awards and are paid upon vesting. Since we are a REIT, dividends are a necessary part
of our business. Furthermore, all dividends are declared by our Board of Trustees. Accordingly, we do not believe that dividends
are a risk in our compensation arrangements.
We
maintain a clawback policy that allows for the recoupment of certain compensation if and to the extent:
| ● | the granting, vesting, or payment of such compensation was predicated upon the achievement of certain
financial results that were subsequently the subject of a material financial restatement; or |
| ● | the recipient of such compensation engaged in intentional or willful misconduct, or failed to supervise
a subordinate employee who engaged in intentional or willful misconduct which the recipient knew, or was reckless in not knowing,
was occurring, and such intentional or willful misconduct resulted in a material violation of law or one of our written policies
that caused significant financial or reputational harm to us. |
Pay for
Performance.
A significant
portion of the total target compensation for our named executive officers is in the form of performance-based incentive compensation,
with the only “fixed” or “guaranteed” compensation in the form of annual base salaries and time-based long-term
incentive awards.
| ● | Annual Cash Incentive Target Opportunity: |
| ° | 70% based on annual pre-defined objective performance measures. |
| ° | 30% based on subjective measures. |
| ● | Annual Long-Term Incentive Target Opportunity: |
| ° | 60% based on future total return to shareholders relative to peer and index groups. |
| ° | 40% based on continued service. |
In
setting the pre-defined objective performance measures for the annual cash incentive target opportunity, multiple factors are considered.
Recap
of 2021 Executive Compensation Program.
The 2021 executive
compensation program consisted of (1) base salary, (2) annual cash incentive opportunity, and (3) annual long-term opportunity.
Base Salaries and
Annual Cash Incentive Awards. Base salaries and annual cash incentives awarded under the 2021 executive compensation program
were as follows:
Officer | |
2021 Base
Salary | | |
Target
Cash Incentive (as
a % of salary) | | |
Target
Cash Incentive | | |
2021
Award | | |
%
of Target | | |
%
Change from 2020 | |
T. Wilson Eglin | |
$ | 785,000 | | |
| 112.5 | % | |
$ | 883,125 | | |
$ | 1,468,931 | | |
| 166 | % | |
| 7 | % |
Beth Boulerice | |
$ | 400,000 | | |
| 100 | % | |
$ | 400,000 | | |
$ | 725,333 | | |
| 181 | % | |
| 20 | % |
Joseph S. Bonventre | |
$ | 420,000 | | |
| 100 | % | |
$ | 420,000 | | |
$ | 761,600 | | |
| 181 | % | |
| 23 | % |
Brendan P. Mullinix | |
$ | 375,000 | | |
| 100 | % | |
$ | 375,000 | | |
$ | 680,000 | | |
| 181 | % | |
| 38 | % |
Lara Johnson | |
$ | 320,000 | | |
| 100 | % | |
$ | 320,000 | | |
$ | 580,267 | | |
| 181 | % | |
| 18 | % |
The target annual cash
incentive opportunity for our named executive officers was a percentage of base salary as follows: 112.5% for Mr. Eglin; and 100%
for the others. Seventy percent (70%) of the annual cash incentive opportunity was based on pre-defined objective measures (from
January 1, 2021 to December 31, 2021) and 30% was based on subjective measures.
Objective Measures
The following sets
forth the pre-defined objective measures, the weighting and the rationale for each measure. In the first quarter of 2022, the Compensation
Committee evaluated the Company’s performance on the objective and subjective measures and made the determinations as detailed
below.
|
Weighting |
|
Target |
|
Actual
at 12/31/2021 |
|
Determination |
Investments |
40% |
|
|
|
|
|
Maximum |
Volume |
|
|
$350 million |
|
$761 million |
|
|
New Development Project Funding |
|
|
$100 million |
|
$290 million |
|
|
Rationale: External growth
is an important part of our 2021 business plan. Assembling a portfolio of high-quality warehouse/distribution facilities is essential
for us to achieve external growth. We separated new development project funding from our investment volume as we expect our development
business to aid our growth.
Result: 2021 was an exceptional
year for investments. We exceeded our targets as we substantially completed our transformation to an industrial focused REIT. We
are now positioned as a growth-orientated company with an extensive development pipeline.
|
Weighting |
|
Target |
|
Actual at 12/31/2021 |
|
Determination |
Dispositions |
15% |
|
|
|
|
|
Maximum |
Volume |
|
|
$200 million |
|
$715 million |
|
|
Rationale: As of December
31, 2020, our non-industrial portfolio represented 9.2% of our gross book value and consisted of 20 properties. Accordingly, for
2021, we lowered the volume and weighting of dispositions year over year. Nonetheless, we expected management to continue to be
a prudent seller of these remaining non-industrial assets as we believe the degree of difficulty of the selling effort may increase
as the amount of non-industrial assets decreases.
Result: Management remained
a prudent seller of non-industrial assets and we exceeded our targets primarily due to the recapitalization of our 22-property
special purpose industrial portfolio. We made significant headway in reducing our non-warehouse/distribution exposure and, at year
end, only 1.9% of our assets were non-warehouse/distribution, excluding held for sale assets.
|
Weighting |
|
Target |
|
Actual at 12/31/2021 |
|
Determination |
Portfolio Management |
25% |
|
|
|
|
|
Target/Maximum |
Composition (Industrial/Other) |
|
|
95%/5% |
|
98.1%/1.9% |
|
|
Industrial Same Store NOI Growth |
|
|
2% |
|
0.9% |
|
|
Warehouse/Distribution Leasing Spreads |
|
|
5% |
|
6.7% |
|
|
Rationale: We believe successful
portfolio management safeguards income and supports internal growth.
| ● | With respect to the composition of our portfolio, we believed that exiting the remaining non-industrial
properties, during 2021, at what we believe are the best prices may take until the end of 2022. As a result, the target for our
industrial assets at the end of 2021 was 95% and not 100%. |
| ● | Our investment strategy is based on our belief that warehouse/distribution rents have better growth
potential than suburban office rents. Accordingly, for 2021, we added two metrics related to leasing. The first was industrial
same store NOI growth and the second was warehouse/distribution leasing spreads. The leasing spreads are the difference between
the expiring rent per square foot and the renewal or new rent per square foot for leases signed or renewed during 2021. |
Result: Our composition exceeded
our targets and now our portfolio consists of 98.1% warehouse/distribution assets and 1.9% other assets, which include some non-warehouse/distribution
industrial assets. We achieved same store NOI growth and our leasing spreads were strong, but our long-term leases weighed on both
leasing spreads and our same store NOI growth in 2021.
|
Weighting |
|
Target |
|
Actual at 12/31/2021 |
|
Determination |
Balance Sheet |
10% |
|
|
|
|
|
Target |
Credit Rating |
|
|
Maintain current ratings |
|
Maintained |
|
|
Rationale: We take pride
in our balance sheet and the opportunities it provides. In 2013, we became an investment-grade rated issuer and we continually
seek to maintain our ratings.
Result: During 2021, we continued
to manage our balance sheet in favor of flexibility over leveraged returns. We took advantage of a strong debt market to opportunistically
refinance certain of our indebtedness. Our credit ratings were unchanged over the course of 2021.
|
Weighting |
|
Target |
|
Actual at 12/31/2021 |
|
Determination |
ESG |
10% |
|
|
|
|
|
Maximum |
ESG reporting frameworks |
|
|
2 |
|
3 |
|
|
ISS Monthly Governance Score Average |
|
|
3 |
|
1 |
|
|
Rationale: In 2020, our management
commenced, in earnest, efforts to establish an ESG platform. We believe that ESG focused investing and operations are an important
contributor to our ongoing long-term success. However, due to the properties in our portfolio primarily being subject to net leases
where tenants are responsible for maintaining the buildings and are in control of their energy usage and environmental sustainability
practices, our ability to implement ESG initiatives throughout our portfolio may be limited. For 2021, we selected two ESG metrics
that we believed are important objective measurements of our developing ESG platform.
Result: Our ESG program expanded
significantly in 2021 and we reported to the GRESB® Assessment, the Bloomberg Gender-Equality Index and we published our first
annual Corporate Responsibility Report aligned with the Sustainability Accounting Standards Board (SASB) standard. We obtained
a first-place ranking for U.S. Industrial Listed peer group in 2021. We also maintained an ISS Monthly Governance Score Average
of 1, which is the highest score possible.
The determination of
the objective measurements resulted in each named executive officer being entitled to 173.3% of the target objective portion of
the 2021 annual incentive opportunity. The Compensation Committee withheld certain amounts until completion of our audited financial
results. The Compensation Committee retains the ability, in its sole discretion, to clawback any amounts, as appropriate, if audited
financial results would provide for lower incentive payouts.
Subjective Measures
With respect to the
subjective portion of the annual cash incentive opportunity, the Compensation Committee made the following determinations:
Officer |
|
Rationale |
|
%
of Target
Subjective
Portion |
T. Wilson Eglin |
|
In 2015, Mr. Eglin designed a strategic
vision for us that involved the transformation from a primarily office net-leased REIT to an industrial focused REIT with a portfolio
consisting of warehouse and distribution assets in targeted markets. 2021 marked the substantial completion of the transformation
and the results of Mr. Eglin’s strategic vision have resulted in the creation of significant shareholder value. While Mr.
Eglin did not receive maximum subjective bonus, the Compensation Committee, and the rest of the Board of Trustees, believe that
Mr. Eglin has performed exceptionally throughout the transformation.
Overall Transaction Activity:
● Over
$1.5 billion in investment and divestiture activity that led to an increase in our percentage of gross book value from industrial
assets to 98.1%, exceeding our target for the year and substantially completing our transformation.
Earnings Results and Growth:
● While
our earnings were still impacted by from the sale of higher-yielding assets into warehouse/distribution assets, we achieved positive
same store NOI growth and leasing spreads in our industrial portfolio. We believe that we are positioned for growth in funds from
operations in 2023.
Accessing the Capital Markets/Balance
Sheet Strategy:
● Over
$648 million in capital raises, including opportunistic debt refinancing, which further strengthened our balance sheet, and forward
equity sales to help maintain modest leverage levels while growing our development pipeline.
Investor Outreach:
● Enhanced
investor outreach efforts by spending a considerable amount of time with shareholders, analysts and potential investors to discuss
our investment and portfolio strategies. Navigated shareholder activism and mitigated disruption to business.
● Led
our corporate rebranding and changing of name to LXP Industrial Trust, which more accurately reflects our portfolio focus and growth
strategy.
Overall Employee Satisfaction:
● Maintained
high over-all employee morale. Named a winner of the 15th Annual Best Companies to Work for in New York.
In addition, Mr. Eglin has led the preparation
for our Board’s strategic alternatives review process.
|
|
|
150 |
% |
|
|
The Compensation Committee believes that
Mr. Eglin’s strategic vision of an industrial focused REIT in target markets with a strong development pipeline is primarily
responsible for the high returns our shareholders have received in recent years. Mr. Eglin recommended a lower percentage for his
subjective award to allow for each other named executive officer to be awarded a maximum subjective award.
|
|
|
|
|
Beth Boulerice |
|
During 2021, Ms. Boulerice oversaw all
of our financial reporting and planning in a continued virtual environment, including maintaining our corporate model.
Quality & Efficiency of Financial
Reporting:
● Our
independent registered public accounting firm opined that our financial statements present fairly, in all material respects, our
financial position as of December 31, 2021 in conformity with GAAP as set forth in our Annual Report on Form 10-K for the year
ended December 31, 2021.
● Continued
to increase efficiencies in our financial reporting processes through the use of technology.
● Led
our G&A budgeting process and efforts to manage expenses.
● Oversaw
our reporting process and was a member of our disclosure committee.
Quality of internal controls:
● Oversaw
compliance with the requirements of the Sarbanes-Oxley Act of 2002 and our internal controls over financial reporting, including
managing those controls in a virtual environment; and
● Led
the transition of firms from CohnReznick LLP to Ernst & Young LLP for our internal audit function.
● Our
independent registered public accounting firm expressed an unqualified opinion on our internal controls over financial reporting
as set forth in our Annual Report on Form 10-K for the year ended December 31, 2021.
Accessing the capital markets:
● Actively
participated in all of our capital raises, including our opportunistic debt offering, our forward equity offering and the management
of our ATM program.
● Actively
participated in the recapitalization of the special purpose portfolio, including the procurement of secured financing.
● Acted
as primary liaison with credit rating agencies.
Investor Outreach:
● Significant
participation in our marketing efforts and preparation of our investor materials.
Ms. Boulerice also participated in the
preparation for our strategic alternative review process.
|
|
|
200 |
% |
|
|
|
|
|
|
|
Joseph S. Bonventre |
|
During 2021, Mr. Bonventre oversaw our
legal and operational activities and assisted on our strategic activities.
Legal Risk Management:
● Advised
and guided our Board of Trustees on substantially all matters, including shareholder activism and preparation for a strategic
alternatives review process.
● Selected
and monitored all outside counsel assignments.
Efficiency of Operations:
● Led
the continued response to the COVID-19 pandemic, the development of policies related to COVID-19 and other human resource matters.
● Oversaw
our ESG efforts, including our submissions to reporting frameworks.
● Assisted
in monitoring our G&A expenses.
● Actively
participated in our diversity, equity and inclusion efforts.
● Oversaw
our information technology initiatives, including our cybersecurity efforts.
Accessing Capital Markets:
● Actively
participated in all of our capital raises, including our opportunistic debt offering, our forward equity offering and the management
of our ATM program.
Quality of Disclosures and Reporting:
● Assisted
with the preparation and review of our public disclosures and reporting. Was a member of our disclosure committee.
Mr. Bonventre assisted in all of our transaction
activity. He also assisted our rebranding efforts as a member of our rebranding committee.
|
|
|
200 |
% |
Brendan P. Mullinix |
|
During 2021, Mr. Mullinix implemented our
acquisition strategy, overseeing all our investment activity.
Investment Quality & Volume:
● Led
the purchase of 23 industrial assets for an aggregate cost of $758 million.
● Led
the investment of $290 million in development activity.
● Led
the expansion our industrial development pipeline, including the investment in 490 acres of development land.
Development Completion:
● Assisted
in our rebranding efforts as a member of our rebranding committee.
Investor Outreach:
● Participated
in our marketing efforts.
|
|
|
200 |
% |
|
|
|
|
|
|
|
Lara Johnson |
|
During 2021, Ms. Johnson administered our
disposition strategy, overseeing our disposition activity.
Disposition Volume/Joint Venture
Management:
● Managed
the recapitalization of our 22-property special purpose portfolio and the procurement of secured financing.
● Managed
the disposition of 15 additional consolidated properties for an aggregate gross sales price of $277 million
Investor Outreach:
● Participated
in our marketing efforts.
Ms. Johnson also assisted with operational
and leasing matters for the asset management department.
|
|
|
200 |
% |
Overall, the subjective
award percentage for 2021 decreased year over year despite our strong performance, but solely due to Mr. Eglin’s recommendation
of a lower percentage for his subjective award. Our Compensation Committee believes that our named executive officers worked well
as a team to overcome the challenges that 2021 presented and substantially complete our transformation to an industrial focused
REIT.
Annual Long-Term
Incentive Award. The 2021 annual long-term incentive award was disclosed in the proxy statement for the 2021 Annual Meeting
of Shareholders. The 2021 awards are exactly the same as the 2022 long-term incentive awards described below, but with a performance
period of January 1, 2021 to December 31, 2023, a different index and a slightly different peer group. The awards granted were
as follows:
| |
Performance-Based
Opportunity | | |
| | |
| |
Officer | |
Threshold | | |
Target | | |
Maximum | | |
Service-Based Award | | | Total
Target Opportunity | |
T. Wilson Eglin | |
$ | 810,000 | | |
$ | 1,620,000 | | |
$ | 3,240,000 | | |
$ | 1,080,000 | | |
$ | 2,700,000 | |
Beth Boulerice | |
$ | 120,000 | | |
$ | 240,000 | | |
$ | 480,000 | | |
$ | 160,000 | | |
$ | 400,000 | |
Joseph S. Bonventre | |
$ | 210,000 | | |
$ | 420,000 | | |
$ | 840,000 | | |
$ | 280,000 | | |
$ | 700,000 | |
Brendan P. Mullinix | |
$ | 180,000 | | |
$ | 360,000 | | |
$ | 720,000 | | |
$ | 240,000 | | |
$ | 600,000 | |
Lara Johnson | |
$ | 75,000 | | |
$ | 150,000 | | |
$ | 300,000 | | |
$ | 100,000 | | |
$ | 250,000 | |
Performance-Based
Opportunity of Outstanding Long-Term Incentive Awards.
As
a result of our strong relative performance, the percentile rankings of our performance-based long-term incentive awards were
high. This resulted in the vesting at maximum for the peer group and index performance awards. The following is the result of
the performance-based opportunity portion of the long-term incentive awards granted in 2019 for the performance period ended on
December 31, 2021:
Performance
Period Start Date | |
Total
Return(1) | |
Peer
Group Percentile Ranking | |
Peer
Group Payout as a Percentage of Target | |
Index
Percentile Ranking | |
Index
Payout as a Percentage of Target |
1/1/2019 | |
94% | |
83.33% | |
200% | |
76.36% | |
200% |
| 1. | Equal
to the sum of (i) dividends earned in performance period, (ii) reinvestment income from such dividends, and (iii) the average
closing price over the 20 trading days ended on the end of the performance period, divided by the average closing price over the
20 trading days beginning at the start of the performance period, minus 1.00. |
The
following table shows the values realized based on the grant date value and the market value on January 3, 2022, which was the
date of vesting:
Officer | |
Grant
Date Value | | |
Market
Value | |
T. Wilson Eglin | |
$ | 1,292,809 | | |
$ | 4,112,515 | |
Beth Boulerice | |
$ | 154,422 | | |
$ | 491,226 | |
Joseph S. Bonventre | |
$ | 269,337 | | |
$ | 856,778 | |
Brendan P. Mullinix | |
$ | 209,004 | | |
$ | 664,857 | |
Lara Johnson | |
$ | 183,149 | | |
$ | 582,610 | |
Accrued
dividends were also paid on the awards that vested upon vesting.
The
following is a summary of the performance-based opportunity portion of the long-term incentive awards granted in 2020 and 2021
assuming the performance period for each award ended on December 31, 2021:
Performance
Period Start Date | |
Total Return(1) | |
Peer Group
Percentile Ranking | |
Peer Group
Estimated Payout as a Percentage of Target | |
Index Percentile
Ranking | |
Index
Estimated
Payout as a Percentage of Target |
1/1/2020 | |
52.34% | |
66.67% | |
166.67% | |
78.44% | |
200% |
1/1/2021 | |
53.83% | |
61.54% | |
146.15% | |
76.16% | |
200% |
1.
Same as above.
The
actual payouts for the 2020 awards will be disclosed in the proxy statement for the 2023 Annual Meeting of Shareholders and the
actual payouts for the 2021 awards will be disclosed in the proxy statement for the 2024 Annual Meeting of Shareholders.
Correlation
between CEO Compensation and Performance.
A
significant portion of our Chief Executive Officer’s compensation is long-term and equity based. As a result, the amounts
in the summary compensation table are not the same as realizable pay. Realizable pay includes Salary, Non-Equity Incentive Plan
Compensation, Nonqualified Deferred Compensation Earnings and All Other Compensation from the Summary Compensation Table below
for the applicable year and
the value realized upon vesting of share awards for the applicable years. Our share awards consist of the following:
| ● | Service-based
equity awards: Fair value of the award is based on the closing price of the common
shares on the date of grant (or, if the date of grant was not a trading day, the last
trading day prior to the date of grant) and does not reflect any time-based vesting
conditions or service period even though it is not “realized” pay. |
| ● | Performance-based
equity awards: Fair value of the award is determined using a Monte Carlo simulation
model, which is an estimation of the value based on hypothetical models. However,
if such performance is never achieved, the awards will not result in “realized”
pay. |
Elements
of Compensation Program Applicable to Named Executive Officers for 2022.
Base
Salary. The Compensation Committee believes that base salaries provide our named executive officers with a degree of financial
certainty and stability and are essential in attracting and retaining highly qualified individuals. For 2022, the Compensation
Committee approved increases in base salaries for our named executive officers as noted below to ensure base salaries, and, in
certain situations, overall compensation, remains competitive and in line with their roles and responsibilities. Base salaries
are as follows:
Officer | |
2022
Base Salary | | |
2021
Base Salary | | |
%
Change |
T. Wilson Eglin | |
$ | 800,000 | | |
$ | 785,000 | | |
2 | % |
Beth Boulerice | |
$ | 440,000 | | |
$ | 400,000 | | |
10 | % |
Joseph S. Bonventre | |
$ | 500,000 | | |
$ | 420,000 | | |
19 | % |
Brendan P. Mullinix | |
$ | 440,000 | | |
$ | 375,000 | | |
17 | % |
Lara Johnson | |
$ | 375,000 | | |
$ | 320,000 | | |
17 | % |
Annual
Cash Incentive Opportunity. The annual cash incentive opportunity is designed to supplement the cash compensation of our
named executive officers so that cash compensation is competitive within our industry and peer groups and properly rewards our
named executive officers for their performance and their efforts for meeting specified objectives. The annual cash incentive opportunity
for the 2022
executive compensation program for our named executive officers will be a percentage of base salary as follows:
Officer | |
Threshold | | |
Target | | |
Maximum | |
T. Wilson Eglin | |
56.25 | % | |
$ | 450,000 | | |
| 112.5 | % | |
$ | 900,000 | | |
| 225 | % | |
$ | 1,800,000 | |
Beth Boulerice | |
50 | % | |
$ | 220,000 | | |
| 100 | % | |
$ | 440,000 | | |
| 200 | % | |
$ | 880,000 | |
Joseph S. Bonventre | |
50 | % | |
$ | 250,000 | | |
| 100 | % | |
$ | 500,000 | | |
| 200 | % | |
$ | 1,000,000 | |
Brendan P. Mullinix | |
50 | % | |
$ | 220,000 | | |
| 100 | % | |
$ | 440,000 | | |
| 200 | % | |
$ | 880,000 | |
Lara Johnson | |
50 | % | |
$ | 187,500 | | |
| 100 | % | |
$ | 375,000 | | |
| 200 | % | |
$ | 750,000 | |
Our
Chief Executive Officer’s target total cash compensation (base salary plus target annual cash incentive) of $1,700,000 is
approximately 0.2% less than the average target total cash compensation in the average of the two 2021 peer groups, which we believe
is in-line with market.
Seventy
percent of the annual cash incentive opportunity for our named executive officers will be determined by predefined objective
performance measures based on our 2022 business plan for the period commencing January 1, 2022 and ending December 31, 2022.
The objective performance measures and the Compensation Committee’s determination of whether an item was met will be
disclosed in the proxy statement for the 2023 Annual Meeting of Shareholders.
The
remaining 30% of the annual cash incentive will be based on subjective factors, similar to the factors discussed with respect
to the 2021 Annual Cash Incentive Opportunity above.
Long-Term
Incentive Opportunity. The long-term incentive opportunity is designed to increase the ownership of us by our named executive
officers, while motivating long-term performance, encouraging long-term dedication to us and operating as a retention mechanism.
No performance-based shares are earned for results below the threshold level.
The
long-term incentive opportunity for the 2022 executive compensation program for our named executive officers is a long-term incentive
award consisting of a mix of performance-based non-vested shares and service-based non-vested shares. Vesting for performance-based
non-vested shares is tied to our total shareholder return relative to other REITs, which we think is more appropriate than absolute
total shareholder return.
Type: |
|
Performance-Based
Non-Vested Shares |
|
Service-Based
Non-Vested Shares |
Amount
of Target Award: |
|
30% |
|
30% |
|
40% |
Comparator
Group: |
|
MSCI
US REIT Index |
|
Competitor
peer group(1) |
|
N/A |
Vesting
Conditions: |
|
Cliff-based
vesting after three-year performance period commencing January 1, 2022.
Performance
Levels
Threshold:
33rd Percentile
Target:
50th Percentile
Maximum:
75th Percentile
Straight-line
interpolation is used to determine awards for results between performance levels. |
|
Pro-rata
vesting annually over three years. |
Dividends |
|
Accrue
and are only payable if and to the extent the shares vest. |
|
Currently
paid. |
Type: |
|
Performance-Based
Non-Vested Shares |
|
Service-Based
Non-Vested Shares |
Rationale |
|
Performance assessments within our applicable industry group and competitor peer group similar to shareholder comparison when making an investment decision. |
|
Enhance retention and promote longer-term equity ownership in us. |
| (1) | Initially
consisting of: Broadstone Net Lease, Inc. (BNL), EastGroup Properties, Inc. (EGP), Essential
Properties Realty Trust, Inc. (EPRT), First Industrial Realty Trust Inc. (FR), Getty Realty
Corp. (GTY), National Retail Properties, Inc. (NNN), PS Business Parks, Inc. (PSB), Rexford
Industrial Realty, Inc. (REXR), Stag Industrial, Inc. (STAG), STORE Capital Corporation (STOR),
Terreno Realty Corporation (TRNO), and W.P. Carey Inc. (WPC). |
The
long-term incentive opportunity is as follows:
| |
Performance-Based
Opportunity | | |
Service-Based | | |
Total Target | | |
Change |
Officer | |
Threshold | | |
Target | | |
Maximum | | |
Award | | |
Opportunity | | |
from
2020 |
T. Wilson Eglin | |
$ | 900,000 | | |
$ | 1,800,000 | | |
$ | 3,600,000 | | |
$ | 1,200,000 | | |
$ | 3,000,000 | | |
11 | % |
Beth Boulerice | |
$ | 180,000 | | |
$ | 360,000 | | |
$ | 720,000 | | |
$ | 240,000 | | |
$ | 600,000 | | |
50 | % |
Joseph S. Bonventre | |
$ | 375,000 | | |
$ | 750,000 | | |
$ | 1,500,000 | | |
$ | 500,000 | | |
$ | 1,250,000 | | |
79 | % |
Brendan P. Mullinix | |
$ | 240,000 | | |
$ | 480,000 | | |
$ | 960,000 | | |
$ | 320,000 | | |
$ | 800,000 | | |
33 | % |
Lara Johnson | |
$ | 180,000 | | |
$ | 360,000 | | |
$ | 720,000 | | |
$ | 240,000 | | |
$ | 600,000 | | |
140 | % |
The
target long-term incentive opportunity for our Chief Executive Officer of $3,000,000 is approximately 1.1% more than the average
of the average target long-term incentive award in the two peer groups, which we believe is in-line with market.
The
number of performance-based non-vested shares (calculated using maximum opportunity level for accounting purposes) and service-based
non-vested shares granted and issued was based on the closing price of our common shares on January 6, 2022 (the date specified
in the Compensation Committee’s approval), which was $14.58 per share; with the number of performance-based non-vested shares
rounded to the nearest share and the number of service-based non-vested shares rounded up to the nearest 10 shares to avoid fractional
shares when vesting. We expect to disclose the amount of performance-based non-vested shares that vest in our definitive proxy
statement for the 2024 Annual Meeting of Shareholders.
CEO
Total Target Direct Compensation
Companywide
Retirement and Health and Welfare Benefits.
General.
In addition to the executive compensation programs outlined in this proxy statement, our named executive officers participate
in retirement and health and welfare benefits that are available to all employees with no distinction made among any groups of
employees other than as required by applicable tax rules. We do not believe that any of these benefits are excessive or above
market.
COMPENSATION
TABLES
Summary
Compensation Table
The
following table sets forth summary information concerning the compensation earned by our named executive officers for the fiscal
years ended December 31, 2021, 2020 and 2019.
Name
and Principal Position |
|
Fiscal
Year |
|
Salary
($)(1) |
|
Bonus
($) |
|
Share
Awards
($)(2) |
|
Option
Awards
($) |
|
Non-Equity
Incentive
Plan
Compensation
($)(3) |
|
Change
in
Pension
Value and
Nonqualified
Deferred
Compensation
Earnings
($)(4) |
|
All
Other
Compensation
($)(5) |
|
Total
($) |
T. Wilson Eglin
Chief Executive Officer
and President |
|
2021 |
|
785,000 |
|
— |
|
3,216,612 |
|
— |
|
1,468,931 |
|
710,586 |
|
1,813,056 |
|
7,994,185 |
|
2020 |
|
765,000 |
|
— |
|
2,664,761 |
|
— |
|
1,367,318 |
|
54,962 |
|
859,341 |
|
5,711,382 |
|
2019 |
|
750,000 |
|
— |
|
2,012,809 |
|
— |
|
1,425,000 |
|
378,848 |
|
1,136,857 |
|
5,703,514 |
Beth Boulerice
Executive Vice President,
Chief Financial Officer and
Treasurer |
|
2021 |
|
400,000 |
|
— |
|
476,586 |
|
— |
|
725,333 |
|
— |
|
147,400 |
|
1,749,319 |
|
2020 |
|
380,000 |
|
— |
|
371,948 |
|
— |
|
603,725 |
|
— |
|
81,914 |
|
1,437,587 |
|
2019 |
|
350,104 |
|
— |
|
240,494 |
|
— |
|
500,000 |
|
— |
|
140,343 |
|
1,230,941 |
Joseph S. Bonventre
Executive Vice President,
Chief Operating Officer, General
Counsel and Secretary |
|
2021 |
|
420,000 |
|
— |
|
834,021 |
|
— |
|
761,600 |
|
— |
|
258,967 |
|
2,274,588 |
|
2020 |
|
390,000 |
|
— |
|
621,840 |
|
— |
|
619,613 |
|
— |
|
139,325 |
|
1,770,778 |
|
2019 |
|
375,000 |
|
— |
|
419,394 |
|
— |
|
565,000 |
|
— |
|
253,303 |
|
1,612,697 |
Brendan Mullinix
Executive Vice President,
and Chief Investment Officer |
|
2021 |
|
375,000 |
|
— |
|
714,876 |
|
— |
|
680,000 |
|
— |
|
170,307 |
|
1,940,183 |
|
2020 |
|
310,000 |
|
— |
|
333,192 |
|
— |
|
492,513 |
|
— |
|
94,671 |
|
1,230,376 |
|
2019 |
|
300,000 |
|
— |
|
325,445 |
|
— |
|
500,000 |
|
— |
|
167,517 |
|
1,292,962 |
Lara Johnson
Executive Vice President |
|
2021 |
|
320,000 |
|
— |
|
297,919 |
|
— |
|
580,267 |
|
— |
|
193,978 |
|
1,392,164 |
|
2020 |
|
310,000 |
|
— |
|
222,166 |
|
— |
|
492,513 |
|
— |
|
106,646 |
|
1,131,325 |
|
2019 |
|
300,000 |
|
— |
|
285,218 |
|
— |
|
425,000 |
|
— |
|
188,298 |
|
1,198,516 |
| (1) | The
amounts shown include amounts earned but a portion of which may be deferred at the election of the officer under our 401(k) Plan. |
| (2) | Equals
the aggregate grant date fair value of awards granted in the applicable year computed in accordance with Financial Accounting
Standards Board Accounting Standard Codification Topic 718. The fair value of share awards subject to time-based vesting conditions
or service periods is based on the closing price of the common shares on the date of grant (or, if the date of grant was not a
trading day, the last trading day prior to the date of grant) and does not reflect any time-based vesting conditions or service
period. The fair value of share awards subject to performance-based vesting conditions is determined using a Monte Carlo simulation
model and the amount set forth above assumes “maximum” performance. |
| (3) | Amounts
were paid pursuant to a non-equity incentive plan described in the applicable year’s
definitive proxy statement. |
| (4) | Non-qualified
deferred compensation consists solely of a trust established for the benefit of Mr. Eglin, into which, in previous years, he had
the option to place non-vested common share awards. Dividends on these shares are the same as all those paid on all common shares
and are paid by us to the trust, which makes a corresponding distribution to the participant. Earnings consist of dividends and
increase in market value of the common shares in the trust. None of the earnings were above-market. See “Non-Qualified Deferred
Compensation,” below. |
| (5) | Amount
represents: (i) dividends paid on service-based non-vested common shares and accrued dividends paid upon vesting of performance-based
non-vested common shares and long-term retention non-vested common shares, (ii) the dollar value of life insurance premiums paid
by us during the applicable fiscal year with respect to portable life insurance policies for the life of our Chief Executive Officer,
and (iii) contributions by us to the executive officer’s account under our 401(k) Plan. The premiums paid by us under company
sponsored health care insurance, dental insurance, long-term disability insurance and life insurance available to all employees,
are excluded. The following table details the 2021 other compensation amounts for each executive officer: |
Executive | |
Dividends Paid on Certain Equity Awards(1) | | |
Company- Paid Life Insurance Premiums | | |
401(k) Company Contributions | | |
Total | |
T. Wilson Eglin | |
$ | 1,797,242 | | |
$ | 1,314 | | |
$ | 14,500 | | |
$ | 1,813,056 | |
Beth Boulerice | |
$ | 132,900 | | |
$ | — | | |
$ | 14,500 | | |
$ | 147,400 | |
Joseph S. Bonventre | |
$ | 244,467 | | |
$ | — | | |
$ | 14,500 | | |
$ | 258,967 | |
Brendan P. Mullinix | |
$ | 155,807 | | |
$ | — | | |
$ | 14,500 | | |
$ | 170,307 | |
Lara Johnson | |
$ | 179,478 | | |
$ | — | | |
$ | 14,500 | | |
$ | 193,978 | |
| (6) | Includes
dividends paid on service-based non-vested common shares and accrued dividends paid on vesting of performance-based non-vested
common shares and long-term retention grants. |
Grants
of Plan-Based Awards
The
following table sets forth summary information concerning all grants of plan-based awards made to the named executive officers
during the fiscal year ended December 31, 2021.
| |
| |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
All Other | | |
| | |
| |
| |
| |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Option | | |
| | |
| |
| |
| |
| | |
| | |
| | |
Estimated Future Payouts | | |
All Other | | |
Awards; | | |
| | |
Grant Date | |
| |
| |
Estimated Future Payouts Under | | |
Under Equity Incentive | | |
Share | | |
Number | | |
Exercise | | |
Fair Value | |
| |
| |
Non-Equity Incentive Plan Awards | | |
Plan Awards | | |
Awards; | | |
of Shares | | |
Price of | | |
of Share | |
| |
| |
(CASH) ($) (1) | | |
(SHARES) (#) | | |
Number | | |
Underlying | | |
Option | | |
and Option | |
| |
| |
| | |
| | |
| | |
| | |
| | |
| | |
of Shares | | |
Option | | |
Awards | | |
Awards | |
Name | |
Grant Date | |
Threshold | | |
Target | | |
Maximum | | |
Threshold | | |
Target | | |
Maximum | | |
(#) | | |
Awards | | |
($) | | |
($) | |
T. Wilson Eglin | |
1/5/2021 | |
| — | | |
| — | | |
| — | | |
79,961 | | |
159,922 | | |
319,843 | | |
106,620 | | |
— | | |
— | | |
3,216,612 | |
| |
3/30/2021 | |
$ | 441,563 | | |
$ | 885,125 | | |
$ | 1,776,250 | | |
— | | |
— | | |
— | | |
— | | |
— | | |
— | | |
— | |
Beth Boulerice | |
1/5/2021 | |
| — | | |
| — | | |
| — | | |
11,847 | | |
23,693 | | |
47,385 | | |
15,800 | | |
— | | |
— | | |
476,586 | |
| |
3/30/2021 | |
$ | 200,000 | | |
$ | 400,000 | | |
$ | 800,000 | | |
— | | |
— | | |
— | | |
— | | |
— | | |
— | | |
— | |
Joseph S. Bonventre | |
1/5/2021 | |
| — | | |
| — | | |
| — | | |
20,731 | | |
41,462 | | |
82,923 | | |
27,650 | | |
— | | |
— | | |
834,021 | |
| |
3/30/2021 | |
$ | 210,000 | | |
$ | 420,000 | | |
$ | 840,000 | | |
— | | |
— | | |
— | | |
— | | |
— | | |
— | | |
— | |
Brendan P. Mullinix | |
1/5/2021 | |
| — | | |
| — | | |
| — | | |
17,770 | | |
35,539 | | |
71,077 | | |
23,700 | | |
— | | |
— | | |
714,876 | |
| |
3/30/2021 | |
$ | 187,500 | | |
$ | 375,000 | | |
$ | 750,000 | | |
— | | |
— | | |
— | | |
— | | |
— | | |
— | | |
— | |
Lara Johnson | |
1/5/2021 | |
| — | | |
| — | | |
| — | | |
7,404 | | |
14,808 | | |
29,616 | | |
9,880 | | |
— | | |
— | | |
297,919 | |
| |
3/30/2021 | |
$ | 160,000 | | |
$ | 320,000 | | |
$ | 640,000 | | |
— | | |
— | | |
— | | |
— | | |
— | | |
— | | |
— | |
| (1) | See
“Compensation Discussion and Analysis — Recap of 2021 Executive Compensation Program,” above, for
the actual payouts. Share amounts are rounded. |
Outstanding
Equity Awards at Fiscal Year-End
The
following table sets forth summary information concerning outstanding equity awards held by each of the named executive officers
as of December 31, 2021.
| |
Option Awards | | |
Share Awards | |
Name | |
Number of Securities Underlying Unexercised Options (#) Exercisable | | |
Number of Securities Underlying Unexercised Options (#) Unexercisable | | |
Option Exercise Price ($) | | |
Option Expiration Date | | |
Number of Shares or Units That Have Not Vested(2) (#) | | |
Market Value of Shares or Units That Have Not Vested ($)(1) | | |
Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested(3) (#) | | |
Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested ($)(1) | |
T. Wilson Eglin | |
— | | |
— | | |
— | | |
— | | |
271,503 | | |
4,240,877 | | |
857,296 | | |
12,365,307 | |
Beth Boulerice | |
— | | |
— | | |
— | | |
— | | |
32,754 | | |
511,617 | | |
117,048 | | |
1,679,353 | |
Joseph S. Bonventre | |
— | | |
— | | |
— | | |
— | | |
57,890 | | |
904,242 | | |
201,679 | | |
2,893,464 | |
Brendan P. Mullinix | |
— | | |
— | | |
— | | |
— | | |
42,027 | | |
656,462 | | |
148,013 | | |
2,118,369 | |
Lara Johnson | |
— | | |
— | | |
— | | |
— | | |
26,603 | | |
468,444 | | |
89,922 | | |
1,312,861 | |
| (1) | Market
value has been calculated using the closing price of our common shares on the NYSE on December 31, 2021, which was $15.62 per
share. For 2019 performance share awards, actual vesting based on performance was used. For 2020 and 2021 performance share awards,
maximum performance was assumed. |
| (2) | The
shares set forth above vest (subject to continued service) as follows: |
| |
| 1/2022 | | |
| 1/2023 | | |
| 1/2024 | |
T. Wilson Eglin | |
| 170,259 | | |
| 65,704 | | |
| 35,540 | |
Beth Boulerice | |
| 18,011 | | |
| 9,477 | | |
| 5,266 | |
Joseph S. Bonventre | |
| 32,417 | | |
| 16,257 | | |
| 9,216 | |
Brendan P. Mullinix | |
| 22,453 | | |
| 11,674 | | |
| 7,900 | |
Lara Johnson | |
| 17,500 | | |
| 5,809 | | |
| 3,294 | |
| (3) | The
shares set forth above vest (subject to continued service and achievement of performance) as follows: |
| |
| 1/2022 | | |
| 1/2023 | | |
| 1/2024 | |
T. Wilson Eglin | |
| 266,010 | | |
| 271,443 | | |
| 319,843 | |
Beth Boulerice | |
| 31,774 | | |
| 37,889 | | |
| 47,385 | |
Joseph S. Bonventre | |
| 55,419 | | |
| 63,337 | | |
| 82,923 | |
Brendan P. Mullinix | |
| 43,005 | | |
| 33,931 | | |
| 71,077 | |
Lara Johnson | |
| 37,685 | | |
| 22,621 | | |
| 29,616 | |
Option
Exercises and Stock Vested
The
following table sets forth summary information concerning option exercises and vesting of stock awards for each of the named executive
officers during the year ended December 31, 2021.
|
|
Option Awards | | |
Share Awards | |
Name |
|
Number of Shares Acquired
on Exercise (#) | |
|
Value Realized on Exercise
($)(1) | | |
Number of Shares Acquired
on Vesting (#) | | |
Value Realized on Vesting
($)(2) | |
T. Wilson Eglin |
|
| — | |
|
| — | | |
| 691,476 | | |
| 7,417,398 | |
Beth Boulerice |
|
| — | |
|
| — | | |
| 56,004 | | |
| 597,444 | |
Joseph S. Bonventre |
|
| — | |
|
| — | | |
| 96,711 | | |
| 1,038,174 | |
Brendan P. Mullinix |
|
| — | |
|
| — | | |
| 63,432 | | |
| 678,205 | |
Lara Johnson |
|
| — | |
|
| — | | |
| 71,148 | | |
| 763,122 | |
| (1) | The
value realized on exercise is calculated as the product of (a) the number of common shares for which the share options were exercised
and (b) the excess of the closing price of our common shares on the NYSE on the day before the date of exercise (or for a broker
assist exercise, at the price the underlying common shares were sold) over the applicable exercise price per share option. Includes
shares withheld to satisfy exercise price and tax obligations, as applicable. |
| (2) | The
value realized on vesting is calculated as the product of (a) the number of non-vested common shares that vested and (b) the closing
price of our common shares on the NYSE on the day used for calculation of taxable income. Includes shares withheld to satisfy
tax obligations. Excludes accrued dividends, if any, which are in All Other Compensation in the “Summary Compensation Table”
above. |
Pension
Benefits
We
do not provide any pension benefits to the named executive officers. We maintain a 401(k) Plan as disclosed above.
Non-Qualified
Deferred Compensation
The
following table sets forth summary information concerning non-qualified deferred compensation for each of the named executive
officers during the year ended December 31, 2021. Non-qualified deferred compensation consists solely of a trust established for
the benefit of Mr. Eglin in which in previous years Mr. Eglin had the option to place non-vested common share awards. Dividends
on these shares are the same as all those paid on all common shares and are paid by us to the trust, which makes a corresponding
distribution to Mr. Eglin. Earnings consist of dividends paid and the change in market value of the common shares in the trust.
The earnings are included in the Summary Compensation Table above.
Name |
|
Executive
Contributions in 2021 ($) | |
|
Registrants
Contributions in 2021 ($) | | |
Aggregate
Earnings in 2021 ($) | |
Aggregate
Withdrawals/ Distributions in 2021 ($) | |
Aggregate
Balance at December 31, 2021 ($)(1) | |
T. Wilson Eglin |
|
| — | |
|
| — | | |
| 710,586 | |
| 56,271 | |
| 2,044,080 | |
Beth Boulerice |
|
| — | |
|
| — | | |
| — | |
| — | |
| — | |
Joseph S. Bonventre |
|
| — | |
|
| — | | |
| — | |
| — | |
| — | |
Brendan P. Mullinix |
|
| — | |
|
| — | | |
| — | |
| — | |
| — | |
Lara Johnson |
|
| — | |
|
| — | | |
| — | |
| — | |
| — | |
| (1) | In
accordance with the trust agreement, complete distribution/withdrawal of Mr. Eglin’s account will be made in the event of
a change in control or termination of Mr. Eglin’s employment. |
Potential
Payments upon Termination or Change in Control
As
of December 31, 2021, each of the named executive officers had the right to receive severance compensation upon the occurrence
of certain termination events under a severance arrangement applicable to certain executive officers. None of our named executive
officers were entitled to any payments in the event of a change of control without a termination of employment.
The
executive severance arrangement provides that the executive officer would be entitled to receive severance payments upon termination
by us without “cause” and termination by the executive officer with “good reason”, including if either
occurs within a “change in control” (as defined in the severance agreement) equal to two and one half times the base
salary, the average of the last two annual cash incentive awards and continuation of certain benefits for two and one half years
for Mr. Eglin and two times the base salary, the average of the last two annual cash incentive awards and continuation of certain
benefits for two years for all others.
Each
of the named executive officers would also be entitled to receive severance payments upon termination for “Disability”
(as defined in the severance agreement) or death equal to one times base salary and continuation of certain benefits for two years.
Upon
certain terminations, (x) all non-vested time-based long-term incentive awards, including long-term retention awards, and all
non-vested but earned performance-based long-term incentive awards shall accelerate, become fully earned and vested, (y) the end
of the performance period for all non-vested but unearned performance-based long-term incentive awards shall be the date of such
termination and a pro rata amount of any of such awards then deemed to be earned awards (determined by the number of completed
days of the performance period for such award divided by the total number of days in such performance period) shall accelerate,
become fully earned and vested (provided, that upon certain events in connection the a change in control, all such awards, instead
of a pro rata amount of such awards, shall then be deemed earned awards), and (z) all unexercised share option awards shall terminate
within six months of such termination of employment.
Our
severance arrangements do not contain: (1) a high multiple, (2) any multiple on long-term incentive awards, (3) vesting of all
non-vested performance-based awards regardless of whether the performance targets were met, or (4) a “gross-up” of
the severance payment to cover the excise taxes imposed by Section 4999 of the Internal Revenue Code of 1986, as amended, which
we refer to as the Code, on the benefits, thereby providing such benefits to the employee on a net basis, after payment of excise
tax.
The
tables below estimate the payments and benefits to each of the named executive officers assuming they were terminated on December
31, 2021. Continuation of benefits are assumed to be paid by a lump-sum payment at termination based on annualized December 2021
premiums. Bonus portion of severance payment is based on the average of the 2021 and 2020 actual annual cash incentive awards.
Value of accelerated equity awards (1) is based on the closing price of our common shares on the NYSE on December 31, 2021 of
$15.62 per share, and (2) consists of time-based non-vested shares set forth in Outstanding Equity Awards at Fiscal Year-End table
above and a pro rata amount of expected performance-based non-vested shares, based on performance to date and the number of days
completed in the period, and excludes accrued dividends. Each named executive officer is entitled to a pro-rata bonus equal to
the average of the 2021 and 2020 annual cash incentive awards multiplied by a fraction, the denominator of which is 365 and the
numerator of which is the number of days from the beginning of the calendar year of termination to the date of termination, which
is excluded from the total payments and benefits below.
T. Wilson Eglin | |
Without Cause or With Good Reason ($) | | |
Upon a Change in Control (“Single
Trigger”) ($) | | |
Death or
Disability ($) | | |
With Cause or Without Good Reason ($) | |
Base salary portion of severance payment | |
1,962,500 | | |
— | | |
785,000 | | |
— | |
Bonus portion of severance payment | |
3,545,312 | | |
— | | |
— | | |
— | |
Group healthcare benefits | |
101,774 | | |
— | | |
81,419 | | |
— | |
Value of accelerated equity awards | |
12,428,277 | | |
— | | |
12,428,277 | | |
— | |
Total Payments and Benefits | |
18,037,863 | | |
— | | |
13,294,696 | | |
— | |
Beth Boulerice | |
Without
Cause or With Good Reason ($) | | |
Upon a
Change in Control (“Single Trigger”) ($) | | |
Death or
Disability ($) | | |
With Cause
or Without Good Reason ($) | |
Base salary portion of severance payment | |
800,000 | | |
— | | |
400,000 | | |
— | |
Bonus portion of severance payment | |
1,329,058 | | |
— | | |
— | | |
— | |
Group healthcare benefits | |
38,926 | | |
— | | |
38,926 | | |
— | |
Value of accelerated equity awards | |
1,583,113 | | |
— | | |
1,583,113 | | |
— | |
Total Payments and Benefits | |
3,751,097 | | |
— | | |
2,022,039 | | |
— | |
Joseph S. Bonventre | |
Without Cause or With Good Reason ($) | | |
Upon a Change in Control (“Single
Trigger”) ($) | | |
Death or Disability ($) | | |
With Cause or Without Good Reason ($) | |
Base salary portion of severance payment | |
840,000 | | |
— | | |
420,000 | | |
— | |
Bonus portion of severance payment | |
1,381,213 | | |
— | | |
— | | |
— | |
Group healthcare benefits | |
65,717 | | |
— | | |
65,717 | | |
— | |
Value of accelerated equity awards | |
2,748,131 | | |
— | | |
2,748,131 | | |
— | |
Total Payments and Benefits | |
5,035,061 | | |
— | | |
3,233,848 | | |
— | |
Brendan P. Mullinix | |
Without
Cause or With Good Reason ($) | | |
Upon a
Change in Control (“Single Trigger”) ($) | | |
Death or
Disability ($) | | |
With Cause
or Without Good Reason ($) | |
Base salary portion of severance payment | |
750,000 | | |
— | | |
375,000 | | |
— | |
Bonus portion of severance payment | |
1,172,513 | | |
— | | |
— | | |
— | |
Group healthcare benefits | |
28,889 | | |
— | | |
28,889 | | |
— | |
Value of accelerated equity awards | |
1,972,358 | | |
— | | |
1,972,538 | | |
— | |
Total Payments and Benefits | |
3,923,760 | | |
— | | |
2,376,247 | | |
— | |
Lara Johnson | |
Without Cause or With Good
Reason ($) | | |
Upon a Change in Control
(“Single Trigger”) ($) | | |
Death or Disability ($) | | |
With Cause or Without Good
Reason ($) | |
Base salary portion of severance payment | |
640,000 | | |
— | | |
320,000 | | |
— | |
Bonus portion of severance payment | |
1,072,780 | | |
— | | |
— | | |
— | |
Group healthcare benefits | |
3,290 | | |
— | | |
3,290 | | |
— | |
Value of accelerated equity awards | |
1,406,456 | | |
— | | |
1,406,456 | | |
— | |
Total Payments and Benefits | |
3,122,526 | | |
— | | |
1,729,746 | | |
— | |
CEO
Pay Ratio
For
2021, the annual total compensation of our median employee (other than our CEO) was $153,100 and the annual total compensation
of our CEO was $7,994,185, and the ratio of the annual total compensation of our CEO to the median of the annual total compensation
of all employees was estimated to be 52 to 1.
To
identify the median of the annual total compensation of all of our employees we used Medicare wages and tips for all employees
as of December 31, 2020. We used the same median employee as last year since we believe there has been no change to our employee
compensation arrangements that would result in a significant change to the pay ratio. The annual total compensation of our median
employee and our CEO were calculated in accordance with the requirements for the Summary Compensation Table above.
Trustee
Compensation
None
of our employees receives or will receive any compensation for serving as a member of our Board of Trustees or any of its committees.
Our non-employee trustees received the following aggregate amounts of compensation for the year ended December 31, 2021.
Name | |
Fees Earned or
Paid in Cash ($) | | |
Share Awards
($) | | |
Option Awards
($) | | |
Non-Equity Incentive
Plan Compensation ($) | | |
Change in Pension
Value and Nonqualified Deferred Compensation Earnings ($) | | |
All Other Compensation
($) | | |
Total ($) | |
Richard S. Frary | |
80,000 | | |
100,000 | | |
— | | |
— | | |
— | | |
— | | |
180,000 | |
Lawrence L. Gray | |
65,000 | | |
100,000 | | |
— | | |
— | | |
— | | |
— | | |
165,000 | |
Jamie Handwerker | |
50,000 | | |
100,000 | | |
— | | |
— | | |
— | | |
— | | |
150,000 | |
Claire A. Koeneman | |
65,000 | | |
100,000 | | |
— | | |
— | | |
— | | |
— | | |
165,000 | |
Nancy Elizabeth Noe | |
30,890 | | |
61,781 | | |
— | | |
— | | |
— | | |
— | | |
92,671 | |
Howard Roth | |
70,000 | | |
100,000 | | |
— | | |
— | | |
— | | |
— | | |
170,000 | |
In
2021, the non-employee trustee compensation arrangements were as follows:
Retainer
Type | |
Retainer
Amount ($) | |
General Cash | |
$ | 50,000 | |
General Vested Common Share | |
$ | 100,000 | |
Lead Trustee | |
$ | 30,000 | |
Audit Chair | |
$ | 20,000 | |
Compensation Chair | |
$ | 15,000 | |
Nominating and Corporate Governance Chair | |
$ | 15,000 | |
In
2022, the non-employee trustee retainer was increased to $180,000 consisting of $60,000 in cash and $120,000 in vested common
shares. The Lead Trustee and committee chair retainers remained the same.
The
retainers are paid quarterly in arrears and the portion of the retainer paid in common shares will be based on the average closing
price over the applicable quarter.
Non-employee
trustees also receive reimbursement of their out-of-pocket travel costs to attend meetings. Any initial equity award for a newly
appointed or elected trustee will be decided by the Compensation Committee on a case-by-case basis. In 2021, Ms. Noe received
an initial equity award of $50,000 common shares.
Compensation
Committee Report
The
Compensation Committee (the “Compensation Committee”) of the Board of Trustees of LXP Industrial Trust, a Maryland
real estate investment trust (the “Trust”), has reviewed and discussed the Compensation Discussion and Analysis with
management, and based on the review and discussions, the Compensation Committee recommended to our Board of Trustees that the
Compensation Discussion and Analysis be included in the Trust’s proxy statement for the 2022 Annual Meeting of Shareholders
and Annual Report on Form 10-K for the year ended December 31, 2021.
Submitted
by the Compensation Committee of the Board of Trustees
/s/
Lawrence L. Gray, Chairperson
Richard S. Frary
Claire A. Koeneman
Jamie Handwerker
2022
EQUITY-BASED AWARD PLAN
Background
The
Compensation Committee of the Board of Trustees adopted the LXP Industrial Trust 2022 Equity-Based Award Plan, which we refer
to as the 2022 Plan, on March 31, 2022. The 2022 Plan is subject to approval at this Annual Meeting. Below is a summary of the
principal provisions of the 2022 Plan and its operation. A copy of the 2022 Plan is set forth in full in Appendix B to
this proxy statement, and the following description of the 2022 Plan is qualified in its entirety by reference to Appendix
B. Capitalized terms used in this section entitled “2022 Equity-Based Award Plan” that are not otherwise defined
in this section, are defined in Appendix B.
Our
Board of Trustees believes that the 2022 Plan is an important factor in attracting, retaining and motivating employees, consultants,
and trustees of us and our affiliates. Our Board of Trustees believes that we need the flexibility to have an increased reserve
of common shares, which we refer to in this summary as Shares, available for future equity-based awards.
Key
Features of the 2022 Plan
We
believe that the 2022 Plan contains a number of features that reflect compensation and governance best practices, with some of
the key features as follows:
| ● | Limitations
on Individual Grants. The maximum number of shares with respect to which an
award or awards may be granted to any participant in any one taxable year of the Company
may not exceed 500,000 shares (or 75,000 shares with respect to a non-employee trustee),
subject to certain adjustments discussed below. |
| ● | Limitation
on Terms of Share Options and Share Appreciation Rights. The maximum term of
each share option and share appreciation right is ten years. |
| ● | No
Repricings or Cash Buyout of Share Options or Share Appreciation Rights. Without
shareholder approval, we may not amend any share option or share appreciation right to
reduce the exercise price or replace any share option or share appreciation right with
cash or any other award when the price per share of the share option or share appreciation
rights exceeds the fair market value of the underlying shares, in each case except as
discussed below. |
| ● | No In-the-Money Share
Option or Share Appreciation Right Grants. Share options and share appreciation
rights may not be granted with an exercise or base price less than the fair market value
of our common shares on the date of grant. |
| ● | Limitation
on Share Counting. Shares previously subject to awards under the 2022 Plan that
are used to satisfy the exercise price or tax withholding obligations with respect to
such awards or any shares covered by share appreciation rights that were not issued upon
the settlement of such awards may not be reissued pursuant to future awards under the
2022 Plan. |
| ● | Independent
Administration. The Compensation Committee, which consists of non-employee trustees,
generally administers the 2022 Plan. |
| ● | No
reload options. The 2022 Plan does not provide for the granting of additional share
options upon the exercise of previously issued options. |
| ● | No
evergreen funding. The 2022 Plan does not provide for awards to be automatically
granted every year. |
| ● | No
excise tax gross-ups. The 2022 Plan does not provide for a “gross-up”
payment to cover the excise taxes imposed by Section 4999 of the Code on any award, thereby
providing such award to the employee on a net basis, after payment of excise tax. |
| ● | Clawback
Right. The 2022 Plan provides that any award granted under the plan may be subject
to certain provisions of the Dodd-Frank Wall Street Reform and Consumer Protection Act
of 2010 or any other compensation clawback policy that is adopted by the Compensation
Committee and that will require the Company to be able to recoup compensation paid to
its executives under certain circumstances. |
| ● | Increases
in Shares Available for Issuance Require Shareholder Approval. No amendment may be
made to the 2022 Plan that increases the total number of shares reserved for issuance
pursuant to awards (except for equitable adjustments discussed below) unless such amendment
is authorized by shareholder approval. |
Background
and Determination of Share Amounts
The
following factors, among others, were taken into account by the Compensation Committee in approving the proposed 2022 Plan:
| ● | Our
award grant history under our equity plans; |
| ● | Our
historical burn rate under our equity plans; |
| ● | The
number of shares remaining available under our Amended and Restated 2011 Equity-Based
Award Plan for future awards; |
| ● | The
number of outstanding unvested equity awards; and |
| ● | Potential
dilution resulting from the shares available under the proposed 2022 Plan. |
In
setting the number of proposed shares issuable under the 2022 Plan, the Compensation Committee also considered the burn rate and
dilution of our equity-based compensation. The following sets forth our calculation of the burn rate for the last three years:
Year | | |
Options | | |
Full Value Awards | | |
Adjusted Options/Stock SARs + Adjusted Full Value Awards(1) | | |
Weighted Total Shares Outstanding | | |
Adjusted Burn Rate | |
2021 | | |
— | | |
949,573 | | |
2,373,933 | | |
277,640,835 | | |
0.86 | % |
2020 | | |
— | | |
756,380 | | |
1,890,950 | | |
266,914,843 | | |
0.71 | % |
2019 | | |
— | | |
896,807 | | |
2,242,018 | | |
237,642,048 | | |
0.94 | % |
| | |
| | |
| | |
3-Year Average Adjusted Burn Rate: | | |
0.84 | % |
| (1) | Adjusted Full Value is two and one half times the Full Value. |
The
historical amounts shown above are not necessarily indicative of the shares that might be awarded in 2022 and beyond.
Summary
of the 2022 Plan
Purpose. The
purpose of the 2022 Plan is to continue to attract, retain and motivate select Eligible Persons, and to provide incentives and
rewards for superior performance. The 2022 Plan is not intended to affect, and shall not affect, any share options, equity-based
compensation, or other benefits that we may have provided, or may provide in the future, pursuant to any agreement, plan, or program
that is independent of the 2022 Plan. For example, any provisions in the 2022 Plan that were not in the 2011 Plan do not affect any
awards granted under the 2011 Plan.
Shares
Subject to the 2022 Plan. The 2022 Plan provides that, from the Effective Date, a total of 4,000,000 Shares will be
available for issuance under the 2022 Plan (plus any shares subject to awards under
the 2011 Plan). These Shares shall be authorized
but unissued Shares, or Shares that we otherwise hold in treasury or in trust. The number of Shares available for Awards, as well as
the terms of outstanding Awards, is subject to adjustment as provided in the 2022 Plan for stock splits, stock dividends,
recapitalizations and other similar events. If an Award expires or becomes un-exercisable without having been exercised in full or,
with respect to Restricted Shares, Restricted Share Units, or Performance Units, is forfeited to us, the unpurchased Shares (or for
Awards other than Options or SARs, the forfeited Shares) which were subject thereto will become available for future grant or sale
under the 2022 Plan, unless the 2022 Plan has terminated. With respect to SARs, all of the Shares covered by the Award (that is,
Shares actually issued pursuant to a SAR, as well as the Shares that represent payment of the exercise price therefor) will cease to
be available under the 2022 Plan. Shares: (i) used to pay the exercise price of an Award, (ii) used to satisfy the Withholding Tax
obligations related to an Award, or (iii) re-acquired by us on the open market or otherwise using cash proceeds from the exercise of
Options will be deemed used under the 2022 Plan and will not become available for future grant or sale under the 2022 Plan. To the
extent that an Award under the 2022 Plan is paid out in cash rather than Shares, such cash payment will not result in reducing the
number of Shares available for issuance under the 2022 Plan.
Administration. The
Compensation Committee will administer the 2022 Plan; provided, that our Board of Trustees may act in lieu of the Compensation
Committee on any matter. Our Board of Trustees and the Compensation Committee, when exercising discretion under the 2022 Plan
from time to time, are referred to in this summary as the “Committee.”
Subject
to the terms of the 2022 Plan, the Committee has express authority to determine the Eligible Persons who will receive Awards,
the number of Shares, units or dollars to be covered by each Award, and the terms and conditions of Awards. The Committee has
broad discretion to prescribe, amend, and rescind rules relating to the 2022 Plan and its administration, to interpret and construe
the terms of the 2022 Plan and the terms of all Award agreements, and to take all actions necessary or advisable to administer
the 2022 Plan. Within the limits of the 2022 Plan, the Committee may accelerate the vesting of any Award, allow the exercise of
unvested Awards, and may modify, replace, cancel or renew them.
The
2022 Plan provides that we and our affiliates will indemnify members of the Committee and their delegates against any claims,
liabilities or costs arising from the good faith performance of their duties under the 2022 Plan. The 2022 Plan releases these
individuals from liability for good faith actions associated with the 2022 Plan’s administration.
Eligibility. Grants
of Awards may be made to Trustees, Employees, Consultants, and persons to whom an offer of employment has been or is being extended,
all of whom constitute Eligible Persons. The Committee may grant Options that are intended to qualify as Incentive Stock Options,
or ISOs, only to Employees, and may grant all other Awards to Eligible Persons. The 2022 Plan and the discussion below use the
term “Participant” to refer to an Eligible Person who has received an Award. As of March 31, 2022, we had seven
non-employee Trustees, 65 employees and no Consultants eligible to receive Awards under the 2022 Plan. The maximum number of Shares
subject to an Award or Awards granted to any one Participant in any one calendar year may not exceed 500,000 Shares (or 75,000
Shares for non-Employee Trustee), subject to adjustment as provided in the 2022 Plan.
Types
of Awards.
Options. Options
granted under the 2022 Plan provide Participants with the right to purchase Shares at a predetermined exercise price. The
Committee may grant Options that are intended to qualify as ISOs or Options that are not intended to so qualify, referred to
herein as Non-ISOs. The 2022 Plan also provides that ISO treatment may not be available for Options that become first
exercisable in any calendar year to the extent the value of the underlying Shares that are the subject of the Option exceed
$100,000 (based upon the fair market value of the Shares on the Option Grant Date).
Share
Appreciation Rights (SARs). A Share Appreciation Right generally permits a Participant who receives it to receive,
upon exercise, cash and/or Shares equal in value to an amount determined by multiplying (a) the excess of the fair market value,
on the date of exercise, of the Shares with respect to
which
the SAR is being exercised, over the exercise price of the SAR for such Shares by (b) the number of Shares with respect to which the
SARs are being exercised. The Committee may grant SARs in tandem with Options or independently of them.
Exercise
Price for Options and SARs. The exercise price of ISOs, Non-ISOs, and SARs may not be less than 100% of the fair
market value on the grant date of the Shares subject to the Award (110% of fair market value for ISOs granted to employees who,
on the grant date, own stock representing more than 10% of the combined voting power of all classes of our Shares). Conditions
of exercise of such ISOs, Non-ISOs, and SARs may be set forth in the applicable Award agreements.
Exercise
of Options and SARs. To the extent exercisable in accordance with the agreement granting them, an Option or SAR
may be exercised in whole or in part, and from time to time during its term; subject to earlier termination relating to a holder’s
termination of employment or service. Unless otherwise specified in an Award Agreement, the exercise price of Options held by
any Participant will be satisfied through a net exercise by surrendering to the Company Shares otherwise receivable upon exercise
of the Option. The term over which Participants may exercise Options and SARs may not exceed ten years from the date of grant
(five years in the case of ISOs granted to employees who, on the date of grant, own stock representing more than 10% of the combined
voting power of all classes of our Shares).
Subject
to the terms of the agreement evidencing an Option grant, Options and SARs may be exercised during the six-month period after
the Optionee retires, during the six-month period after the Optionee’s termination of service due to death or permanent
Disability, and during the 90-day period after the Optionee’s termination of employment without cause (but in no case later
than the termination date of the Option). The agreements evidencing the grant of an Option may, in the discretion of the Committee,
set forth additional or different terms and conditions applicable to such Option upon a termination or change in status of the
employment or service of the Option holder.
Restricted
Shares, Restricted Share Units, and Unrestricted Shares. Under the 2022 Plan, the Committee may grant Restricted
Shares that are forfeitable until certain vesting requirements are met, may grant Restricted Share Units which represent the right
to receive Shares after certain vesting requirements are met, and may grant unrestricted Shares as to which the Participant’s
interest is immediately vested.
Performance
Awards. The 2022 Plan authorizes the Committee to grant performance-based awards, including arrangements under
which the grant, issuance, retention, vesting and/or transferability of any Performance Award are subject to quantitative and/or
qualitative measures, as determined by the Committee, used to measure the level of performance of the Company or any individual
Participant during a Performance Period. Performance Awards may be denominated or payable in cash, Shares (including, without
limitation, Restricted Shares), other securities, or other Awards.
Dividend
Equivalent Rights (DERs). The Committee may grant DERs to any Eligible Person, and may do so either pursuant to
an Agreement that is independent of any other Award, or through a provision in another Award (other than an Option or SAR) that
DERs attach to the Shares underlying the Award.
Minimum
Vesting for Awards. Awards granted pursuant to the 2022 Plan that are subject to vesting shall become vested on a pro
rata basis over a period of not less than one year following the grant date of such Award; provided, however, such Awards that result
in the issuance of an aggregate of up to 5% of the maximum number of Shares available at any time pursuant to the 2022 Plan may be granted
without respect to such minimum vesting provision.
Forfeiture. Unless
otherwise provided in an agreement granting an Award, we may terminate any outstanding, unexercised, unexpired, unpaid, or deferred
Awards, rescind any exercise, payment or delivery pursuant to the Award, or Recapture any common stock (whether restricted or
unrestricted) or proceeds from the Participant’s sale of Shares issued pursuant to the Award if granted, vested or settled
during a period affected by a Participant’s fraud or misconduct, or a financial restatement.
Income
Tax Withholding. As a condition for the issuance of Shares pursuant to Awards, the 2022 Plan requires satisfaction
of any applicable federal, state, local, or foreign Withholding Tax obligations that
may arise in connection with the award or
the issuance of Shares. The 2022 Plan provides for Withholding Tax to be satisfied through the withholding and cancelling by the
Company of the number of Shares that would otherwise be delivered to the Participant pursuant to the Award and that have aggregate
fair market value as of the date of withholding equal to the Withholding Tax, and, thereafter, to the extent necessary to satisfy
the Withholding Tax.
Non-Transferability
of Awards. Awards may not be sold, pledged, assigned, hypothecated, transferred or disposed of other than by will
or the laws of descent and distribution, except to the extent the Committee permits lifetime transfers in the form of a Non-ISO,
SAR, Restricted Shares, or Performance Shares to charitable institutions, certain family members or related trusts, or as otherwise
approved by the Committee.
Certain
Corporate Transactions. The Committee shall equitably adjust the number of Shares covered by each outstanding Award,
and the number of Shares that have been authorized for issuance under the 2022 Plan but as to which no Awards have yet been granted
or that have been returned to the 2022 Plan upon cancellation, forfeiture or expiration of an Award, the maximum annual Share
limit on Awards to any individual Participant, as well as the price per Share covered by each such outstanding Award, to reflect
any increase or decrease in the number of issued Shares resulting from a stock split, reverse stock split, stock dividend, combination,
recapitalization or reclassification of the Shares, or any other increase or decrease in the number of issued Shares effected
without receipt of consideration by us.
In
addition, in the event of a Change in Control (as defined in the 2022 Plan but subject to the terms of any Award agreements or
any employment or other similar agreement between us or any of our affiliates and a Participant then in effect), each outstanding
Award shall be assumed or a substantially equivalent award shall be substituted by the surviving or successor corporation or a
parent or subsidiary of such surviving or successor corporation. However, that to the extent outstanding Awards are neither being
assumed nor replaced by the successor corporation, the Committee may in its sole and absolute discretion and authority, without
obtaining the approval or consent of our shareholders or any Participant with respect to outstanding Awards, take one or more
of the following actions: (a) accelerate the vesting of Awards for any period so that Awards shall vest (and, to the extent applicable,
become exercisable) as to the Shares that otherwise would have been unvested and provide that our repurchase rights with respect
to Shares issued pursuant to an Award shall lapse; (b) arrange or otherwise provide for payment of cash or other consideration
to Participants in exchange for the satisfaction and cancellation of outstanding Awards; or (c) terminate all or some Awards upon
the consummation of the transaction, provided that the Committee shall provide for vesting of such Awards in full as of a date
immediately prior to consummation of the Change in Control. If an Award is not exercised prior to consummation of a transaction
in which the Award is not being assumed or substituted, such Award shall terminate upon such consummation.
Notwithstanding
the above, in the event a Participant holding an Award assumed or substituted by the successor corporation in a Change in Control is
Involuntarily Terminated by the successor corporation in connection with, or within 12 months (or other period either set forth in an
Award Agreement, or as increased thereafter by the Committee to a period longer than 12 months) following consummation of, the Change
in Control, then any assumed or substituted Award held by the terminated Participant at the time of termination shall accelerate and
become fully vested (and exercisable in full in the case of Options and SARs), and any repurchase right applicable to any Shares shall
lapse in full.
If
we dissolve or liquidate, subject to the terms of any Award Agreements or employment-related agreements between the Company
or any of its Affiliates and any Participant, all Awards will terminate immediately prior to such dissolution or liquidation,
subject to the ability of the Committee to exercise any discretion authorized in the case of a Change in Control.
Term
of the 2022 Plan; Amendments or Termination. The term of the 2022 Plan is ten years from March 31, 2022. Our
Board of Trustees may from time to time, amend, alter, suspend, discontinue or terminate the 2022 Plan; provided that no amendment,
suspension or termination of the 2022 Plan shall materially and adversely affect Awards already granted. Any amendment to the
2022 Plan or any Award
Agreement that results in the repricing of an Option or SAR issued under 2022 Plan shall not be effective
without prior approval of the shareholders of the Company.
Expected
Tax Consequences.
The
following is a summary of the principal U.S. federal income tax consequences to participants and the Company with respect to participation
in the 2022 Plan. This summary is not intended to be exhaustive and does not discuss the income tax laws of any local, state or
foreign jurisdiction in which a participant may reside. The information is based upon current U.S. federal income tax rules and
therefore is subject to change when those rules change. Because the tax consequences to any participant may depend on such participant’s
particular situation, each participant should consult the participant’s tax adviser regarding the federal, state, local,
and other tax consequences of the grant or exercise of a purchase right or the sale or other disposition of Shares acquired under
the 2022 Plan. The 2022 Plan is not qualified under the provisions of Section 401(a) of the Code and is not subject to any
of the provisions of the Employee Retirement Income Security Act of 1974, as amended.
A
Participant who receives an Option or SAR will not have taxable income upon the grant of the Option or SAR. For Non-ISOs and SARs,
the Participant will recognize ordinary income upon exercise in an amount equal to the excess of the fair market value of the
Shares over the exercise price — the appreciation value — on the date of exercise. Any
additional gain or loss recognized upon any later disposition of the Shares generally will be long-term or short-term capital
gain or loss, depending on whether the Shares are held for more than one year.
The
purchase of shares upon exercise of an incentive stock option will not result in any taxable income to the participant, except
for purposes of the alternative minimum tax. Gain or loss recognized by the participant on a later sale or other disposition of
the shares will be capital gain or loss and/or ordinary income depending upon whether the participant holds the shares transferred
upon exercise for a specified period. If the shares are held for the specified period, any gain generally will be taxed at long-term
capital-gain rates. If the shares are not held for the specified period, generally any gain up to the excess of the fair market
value of the shares on the date of exercise over the exercise price will be treated as ordinary income. Any additional gain generally
will be taxable at long-term or short-term capital-gain rates, depending on whether the participant held the shares for more than
one year after the exercise date.
A
participant who receives restricted stock will not have taxable income until vesting unless the participant timely files an election
under Section 83(b) of the Internal Revenue Code to be taxed at the time of grant. The participant will recognize ordinary
income equal to the fair market value of the shares at the time of vesting less the amount paid for such shares (if any) if the
participant does not make such election. Any additional gain or loss recognized upon any later disposition of the shares generally
will be long-term or short-term capital gain or loss, depending on whether participant holds the shares for more than one year.
If a participant timely files a Section 83(b) election, the participant will recognize ordinary income equal to the fair
market value of the shares at the time of purchase or grant less the amount paid for such shares (if any).
A
participant who receives RSUs will not have taxable income upon grant of the stock award; instead, the participant will be taxed
upon settlement of the stock award. The participant will recognize ordinary income equal to the fair market value of the shares
or the amount of cash received by the participant.
Section 409A
imposes certain restrictions on deferred compensation arrangements. Stock awards that are treated as deferred compensation under
Section 409A are intended to meet the requirements of Section 409A.
Prior
to the delivery of any shares or cash pursuant to a stock award (or exercise thereof) or prior to any time the stock award or
shares are subject to taxation or other tax-related items, we and/or the participant’s employer will have the power and
the right to deduct or withhold, or require a participant to remit to us, an amount sufficient to satisfy any tax-related items
or other items that are required to be withheld or deducted with respect to such stock award.
The
Committee may, at its discretion and pursuant to such procedures as it may specify from time to time, permit a participant to
satisfy such withholding or deduction obligations or any other tax-related items, in whole or in part by (without limitation)
paying cash, electing to have us withhold otherwise deliverable cash or shares, or remitting to us proceeds from the immediate
sale of shares otherwise to be delivered to the participant.
The
Company will be entitled to a tax deduction in connection with a stock award under the 2022 Plan only in an amount equal to the
ordinary income realized by the participant at the time the participant recognizes the income. Section 162(m) of the Internal
Revenue Code places a limit of $1 million on the amount of compensation that we may deduct as a business expense in
any year with respect to certain of our most highly paid executive officers. While the Committee considers the deductibility of
compensation as one factor in determining executive compensation, the Committee retains the discretion to award and pay compensation
that is not deductible as it believes that it is in the best interests of our shareholders to maintain flexibility in our approach
to executive compensation and to structure a program that we consider to be the most effective in attracting, motivating and retaining
key employees.
Plan
Benefits
The
Committee will grant Awards under the 2022 Plan at its discretion. Consequently, it is not possible to determine at this time
the amount or dollar value of Awards to be provided under the 2022 Plan under future grants.
Audit
and Audit-Related MATTERS
The
following table presents audit fees and audit related fees and tax fees billed to us by Deloitte.
| |
2021 | | |
2020 | |
Audit fees(1) | |
$ | 1,170,000 | | |
$ | 1,130,000 | |
Audit-related fees(2) | |
| 150,000 | | |
| 170,000 | |
Total audit and audit related fees | |
| 1,320,000 | | |
| 1,300,000 | |
Tax fees(3) | |
| 310,545 | | |
| 290,290 | |
All other fees | |
| — | | |
| — | |
Total fees | |
$ | 1,630,545 | | |
$ | 1,590,290 | |
| (1) | Audit
fees are fees for services rendered for the audit and review of our financial statements. |
| (2) | Audit-related
fees refers to fees for services that are reasonably related to the performance of the
audit or review of our financial statements. |
| (3) | Tax
fees consisted of fees for tax compliance and preparation services. |
The Audit
Committee has determined that the non-audit services provided by the independent registered public accounting firm are compatible with
maintaining the accounting firm’s independence. All of the
services set forth above in the categories “Audit-related fees,” “Tax fees” and “All other fees”
were pre-approved by the Audit Committee, as set forth below.
The
Audit Committee of the Board of Trustees must pre-approve the audit and non-audit services performed by our independent
registered public accounting firm and has adopted appropriate policies in this regard. With regard to fees, annually, the
independent registered public accounting firm provides the Audit Committee with an engagement letter outlining the scope of
the audit services proposed to be performed during the fiscal year. Upon the Audit Committee’s acceptance of and
agreement to the engagement letter, the services within the scope of the proposed audit services are deemed pre-approved
pursuant to this policy. The Audit Committee must pre-approve any change in the scope of the audit services to be performed
by the independent registered public accounting firm and any change in fees relating to any such change. Specific
audit-related services and tax services are pre-approved by the Audit Committee, subject to limitation on the dollar amount
of such fees, which dollar amount is established annually by the Audit Committee. Services not specifically identified and
described within the categories of audit services, audit-related services and tax
services must be expressly pre-approved by
the Audit Committee prior to us engaging any such services, regardless of the amount of the fees involved. The Chairperson of
the Audit Committee is delegated the authority to grant such pre-approvals. The decisions of the Chairperson to pre-approve
any such activity shall be presented to the Audit Committee at its next scheduled meeting. In accordance with the foregoing,
the retention by management of our independent registered public accounting firm for tax consulting services for specific
projects is pre-approved, provided, that the annual cost of all such retentions does not exceed $100,000. The Audit Committee
does not delegate to management its responsibilities to pre-approve services to be performed by our independent registered
public accounting firm.
OTHER
MATTERS
The
Board of Trustees is not aware of any business to come before the Annual Meeting other than (1) the election of trustees, (2)
the advisory, non-binding resolution to approve executive compensation, (3) the amendment to our Declaration of Trust, (4) the
approval of the LXP Industrial Trust 2022 Equity-Based Award Plan, and (5) the proposal to ratify the appointment of Deloitte
& Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022. However, if
any other matters should properly come before the Annual Meeting or any postponement or adjournment thereof, including matters
relating to the conduct of the Annual Meeting, it is intended that proxies in the accompanying form or as authorized via the Internet
or telephone will be voted in respect thereof in accordance with the discretion of the person or persons voting the proxies.
QUESTIONS
AND ANSWERS
How
can I attend the Annual Meeting?
The
Annual Meeting will be a completely virtual meeting of Shareholders, which will be conducted exclusively by webcast. You are entitled
to participate in the Annual Meeting only if you were a Shareholder as of the close of business on the Record Date, or if you
hold a valid proxy for the Annual Meeting. No physical meeting will be held and members of our Board of Trustees and management
will also attend by webcast.
You will be able to attend the
Annual Meeting online and submit your questions during the meeting by visiting www.cesonlineservices.com/lxp22_vm. You also will
be able to vote your shares online by attending the Annual Meeting by webcast.
To participate in the Annual Meeting,
you will need to review the information included on the WHITE proxy card or in the instructions that accompanied your proxy materials.
You must pre-register at www.cesonlineservices.com/lxp22_vm.
If
you hold your shares through an intermediary, such as a bank or broker, you must register in advance using the instructions below.
The
online Annual Meeting will begin promptly at 10:00 a.m., Eastern Time. We encourage you to access the Annual Meeting prior to
the start time leaving ample time for the check-in. Please follow the registration instructions as outlined in this proxy statement.
If you have any questions or require any assistance
with pre-registering, please contact the Company’s proxy solicitor: D.F. King & Co., Inc. at (866) 811-1442
or (212) 269-5550.
How
do I register to attend the Annual Meeting virtually on the Internet?
Registered Shareholders
-- Shareholders of record as of the Record Date may register to participate in the Annual Meeting remotely by visiting the website
www.cesonlineservices.com/lxp22_vm. Please have your WHITE proxy card containing your control number available and follow the instructions
to complete your registration request. After registering, Shareholders will receive a confirmation email with a link and instructions
for accessing the virtual Annual Meeting. Requests to register to participate in the Annual Meeting remotely must be received no later
than 5:00 p.m., Eastern Time, on May 19, 2022.
Beneficial Shareholders.
Shareholders whose shares are held through a broker, bank or other nominee as of the Record Date may register to participate in the Annual
Meeting remotely by visiting the website www.cesonlineservices.com/lxp22_vm.
Please
have your WHITE Voting Instruction Form or other communication containing your control number available and follow the instructions to
complete your registration request. After registering, Shareholders will receive a confirmation email with a link and instructions for
accessing the virtual Annual Meeting. Requests to register to participate in the Annual Meeting remotely must be received no later than
5:00 p.m., Eastern Time, on May 19, 2022.
How
do I cast my vote?
Shareholders
of record may vote (i) by filling out and signing the WHITE proxy card that was included with this Proxy Statement and returning
it in the envelope provided, (ii) by calling the toll-free number found on the WHITE proxy card, or (iii) online at the internet
voting website provided on the WHITE proxy card. Shareholders of record may also vote in person at the Annual Meeting. If you
are a beneficial owner of shares held in street name, you will receive instructions from your broker, bank or other nominee on
how to vote your shares. If you received printed copies of the proxy materials by mail, you may also vote by filling out the voting
instruction form and returning it in the envelope provided. The availability of online or phone voting may depend on the voting
process of the organization that holds your shares. Beneficial owners who want to attend and also vote in person at the Annual
Meeting will need to obtain a legal proxy, in PDF or image (gif, jpg, or png) file format, from the organization that holds their
shares giving them the right to vote their shares in person at the Annual Meeting and by presenting it with their online ballot
during the meeting.
Why
are you holding a virtual meeting instead of a physical meeting?
Attendance
at our past, in-person, annual meetings has been sparse. In 2020, we held our first virtual meeting primarily due to the COVID-19
pandemic.
We
believe that hosting a virtual meeting provides the following benefits:
| ● | Expanded
access, improved communication and cost savings; and |
| ● | Safety
in light of the continuing COVID-19 pandemic. |
In
future years, we expect to continue to provide a virtual option to attend our annual meetings of shareholders.
Who
is entitled to vote?
All
Shareholders of record as of the close of business on the Record Date are entitled to vote at the Annual Meeting. There was no
other class of voting securities of the Company outstanding as of the close of business on the Record Date other than common shares.
What
is the quorum for the Annual Meeting?
In order for any business to be
conducted at the Annual Meeting, the holders entitled to cast a majority of the votes entitled to be cast at the Annual Meeting must be
present, either in person via webcast or represented by proxy. For the purpose of determining the presence of a quorum, abstentions and
broker non-votes, if any, will be counted as present. As of the close of business on the Record Date, 287,868,449 common shares were issued
and outstanding representing an equal number of votes entitled to be cast. Therefore, in order for a quorum to be present, holders of
at least 143,934,225 common shares must be present, either in person via webcast or represented by proxy.
What
is a broker non-vote?
Broker
votes occur when a broker or nominee who has not received voting instructions from the beneficial owner on a “routine”
matter, (as defined by the NYSE), casts a discretionary vote. In contrast, broker non-votes occur when a broker or nominee has
not received voting instructions from the beneficial owner on a “non-routine” matter, as defined by the NYSE and,
therefore, is not permitted under NYSE rules to cast a discretionary vote on that matter. Given the contested nature of the election,
under the rules of the NYSE, if your common shares are held through a broker, bank or other nominee in “street name”
as of the close of business on the record date and you receive proxy materials from L&B, your broker, bank, or other nominee
will only be able to vote your shares with respect to any proposals at the Annual Meeting if you have instructed them how to vote.
Will
my shares be voted if I do not provide my proxy?
Depending
on the proposal, your shares may be voted if they are held in the name of a brokerage firm, even if you do not provide the brokerage
firm with voting instructions, which are broker votes discussed above. The proposal to ratify the appointment of Deloitte &
Touche LLP as our independent registered public accounting firm is generally considered a “routine” matter for which
brokerage firms may vote shares without receiving voting instructions, unless there is a contested matter being voted upon at
the Annual Meeting, as described above. The election of trustees, the advisory resolution on the compensation of our named executive
officers, the amendment to our Declaration of Trust and the approval of the LXP Industrial 2022 Equity-Based Award Plan are also
considered “non-routine matters” and if you do not provide the brokerage firm with voting instructions on these proposals,
your shares will not be voted on these proposals and will be broker non-votes.
How
many votes do I have?
Each
common share outstanding on the Record Date is entitled to one vote for each trustee to be elected at the Annual Meeting and to
cast one vote on each other item properly submitted for consideration at the Annual Meeting.
How
do I vote or authorize a proxy to vote my shares that are held of record by me?
| ● | Via
Internet: Log on to www.cesvote.com and follow the on-screen instructions. You will be prompted
for certain information that can be found on your proxy card. |
| ● | By
Telephone: Call toll-free 1-888-693-8683 and follow the instructions. You will be prompted for
certain information that can be found on your proxy card. |
| ● | In
Person: Vote at the Annual Meeting online via webcast. |
How
do I vote or authorize a proxy to vote my shares that are held by my bank, broker or other nominee?
If
you have shares held by a bank, broker or other nominee (which is also known as holding shares in “street name”),
you may instruct your bank, broker or other nominee to vote your shares by following the instructions that the bank, broker or
other nominee provides to you. Most banks, brokers or other nominees offer voting instructions by mail, telephone and on the Internet.
If your shares are held in “street name,” your bank, broker or other nominee will not vote your shares unless you
provide such instructions to your bank, broker or other nominee on how to vote your shares. If you would like to vote in person
via webcast at the Annual Meeting, you must contact your bank, broker or other nominee and follow your bank’s, broker’s
or other nominee’s instructions, including the instructions on how to obtain a proxy.
Are
dissenters’ or appraisal rights available to Shareholders with respect to any of the proposals at the Annual Meeting?
No
dissenters’ or appraisal rights are available with respect to any of the proposals being submitted to Shareholders for their
consideration at the Annual Meeting.
What
am I voting on?
You
will be voting on the following proposals:
| (1) | to
elect eight trustees to serve until the 2023 Annual Meeting of Shareholders or their
earlier removal or resignation and until their respective successors, if any, are elected
and qualify; |
| (2) | to
consider and vote upon an advisory, non-binding resolution to approve the compensation
of our named executive officers, as disclosed in this proxy statement; |
| (3) | to
consider and vote upon a proposal to amend our Declaration of Trust to increase the number
of authorized shares of beneficial interest; |
| (4) | to
consider and vote upon a proposal to approve the LXP Industrial Trust 2022 Equity-Based
Award Plan; |
| (5) | to
consider and vote upon the ratification of the appointment of Deloitte & Touche LLP
as our independent registered public accounting firm for the fiscal year ending December
31, 2022; and |
| (6) | to
transact such other business as may properly come before the 2022 Annual Meeting of Shareholders
or any adjournment or postponement thereof. |
Will
there be any other items of business on the agenda?
The
Board of Trustees is not presently aware of any other items of business to be properly presented for a vote at the Annual Meeting
other than the proposals noted above. Nonetheless, in case there is an unforeseen need, your proxy gives discretionary authority
to Joseph S. Bonventre and Beth Boulerice, or either of them, with respect to any other matters that might be properly presented
at the meeting or any postponement or adjournment thereof.
Why
am I being asked to vote on executive compensation?
The
Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, which we refer to as the Dodd-Frank Act, requires us, as a
public company, to seek a non-binding advisory vote from our Shareholders to approve the compensation awarded to our named executive
officers, as disclosed in this proxy statement. Based on the non-binding advisory recommendation selecting an annual frequency
of such non-binding advisory votes at the 2017 Annual Meeting of Shareholders, we are currently seeking a vote from Shareholders
on an advisory resolution to approve the compensation awarded to our named executive officers on an annual basis. This advisory
vote is non-binding, but the Board of Trustees considers our Shareholders’ concerns and takes them into account in determinations
concerning our executive compensation program. See “Compensation of Executive Officers,” below. We will next seek
a recommendation on the frequency of such non-binding advisory votes at the 2023 Annual Meeting of Shareholders.
How
many votes are required to act on the proposals?
Assuming a quorum is present at
the Annual Meeting, the affirmative vote of a majority of the votes cast by holders of common shares at the Annual Meeting will be sufficient
for (1) the adoption of the advisory, non-binding resolution to approve the compensation of our named executive officers, (2) the approval
of the LXP Industrial Trust 2022 Equity-Based Award Plan, and (3) the ratification of the appointment of Deloitte & Touche LLP as
our independent registered public accounting firm for the fiscal year ending December 31, 2022. Because the number of nominees to the
Board of Trustees exceeds the number of trustees to be elected, each trustee shall be elected by the vote of a plurality of the votes
cast by shareholders entitled to vote with respect to the election of trustees. The proposal to amend our Declaration of Trust requires
the affirmative vote of a majority of the votes entitled to be cast on the proposal.
If
you abstain or your shares are treated as broker non-votes, your abstention or broker non-votes will have the same effect as a
vote against the proposal to amend our Declaration of Trust. If you abstain or your shares are treated as broker non-votes, your
abstention or broker non-votes will not be counted as votes cast and will have no effect on the result of the vote on (1) the
election of trustees, (2) the resolution to approve, on an advisory, non-binding basis, the compensation of our named executive
officers, (3) the approval of the LXP Industrial Trust 2022 Equity-Based Award Plan, or (4) the ratification of the appointment
of Deloitte & Touche LLP as our independent registered public accounting firm. As noted above, the proposal to ratify the
appointment of Deloitte & Touche LLP as our independent auditors is generally considered a “routine” matter for
which brokerage firms may vote shares without receiving voting instructions, unless there is a contested matter being voted upon
at the Annual Meeting. The election of trustees, the advisory, non-binding resolution on the compensation of our named executive
officers, the amendment to our Declaration of Trust and the approval of the LXP Industrial Trust 2022 Equity-Based Award Plan
are also considered “non-routine matters” and if you do not provide the brokerage firm with voting instructions on
these proposals, your shares will not be voted on these proposals and will be “broker non-votes.”
For
purposes of the election of trustees, a plurality of votes cast means the elected nominee only needs to get more votes than a
competing nominee, so the eight nominees for trustee who receive the most votes will be elected. Thus, if you do not vote for
a nominee, or you “WITHHOLD” authority to vote for a nominee, your vote will not count either “for” or
“against” the nominee.
For
purposes of the remaining proposals properly brought before the Annual Meeting other than the election of trustees and the amendment
to our Declaration of Trust, a majority of votes cast means the number of shares voted “FOR” a proposal must exceed
the number of shares as to which the holders elected to vote “AGAINST” such proposal. For the proposal to amend our
Declaration of Trust, a majority of the votes entitled to be cast means the number of shares voted “FOR” the proposal
must exceed a majority, or be greater than 50%, of the outstanding shares entitled to vote. The votes on (1) the advisory resolution
to approve the compensation of our named executive officers, and (2) the ratification of the appointment of Deloitte & Touche
LLP as our independent registered public accounting firm, are non-binding and serve only as recommendations to the Board of Trustees
and the Audit Committee, as applicable.
What
happens if I authorize my proxy without voting on all proposals?
When
you return a properly executed WHITE proxy card or authorize your proxy telephonically or by the Internet, the shares that the
WHITE proxy card or authorization represents will be voted in accordance with your directions. If you return the signed WHITE
proxy card with no direction on a proposal, other than in the case of broker non-votes, the shares represented by your proxy
will be voted in favor of (FOR) each of our nominees for trustee in Proposal No. 1 and in favor of (FOR) Proposals No. 2, No.
3, No. 4 and No. 5 and will be voted in the discretion of the proxy holder on any other matter that properly comes before
the Annual Meeting.
Why
am I receiving proxy cards with different nominees to the Board of Trustees?
L&B
has notified us that it intends to nominate two individuals for election to our Board of Trustees at the Annual Meeting. You may
receive solicitation materials from L&B, including a proxy statement and [COLOR] proxy card. We are not responsible for the
accuracy of any information provided by or relating to L&B or its nominees contained in solicitation materials filed or disseminated
by or on behalf of L&B or any other statements L&B may make.
L&B’s
nominees have NOT been endorsed by our Board of Trustees. The Board of Trustees unanimously recommends that you disregard any
[COLOR] proxy card that may be sent to you by L&B. Voting against L&B’s nominees on its [COLOR] card is not the
same as voting for our Board of Trustees’ nominees, because a vote against L&B’s nominees on its [COLOR] proxy
card will revoke any previous proxy submitted by you.
What
if I want to change my vote after I return my proxy?
If
you are a Shareholder of record, you may revoke your proxy at any time before its exercise by:
| (1) | delivering
written notice of revocation to our Secretary at c/o LXP Industrial Trust, One Penn Plaza,
Suite 4015, New York, NY 10119-4015; |
| (2) | submitting
to us a duly executed proxy card bearing a later date; |
| (3) | authorizing
a proxy via the Internet or by telephone at a later date; or |
| (4) | attending
the Annual Meeting and voting at the annual meeting online via webcast; |
provided, however, that no such revocation under clause
(1) or (2) shall be effective until written notice of revocation or a later dated proxy card is received by our Secretary on or before
11:59 p.m., Eastern Time, on May 23, 2022.
Participating
in our Annual Meeting will not constitute a revocation of a previously delivered proxy unless you affirmatively indicate at our
Annual Meeting that you intend to vote your shares by voting your shares online during the Annual Meeting webcast.
If
you have shares held by a broker, you must follow the instructions given by your broker to change or revoke your voting instructions.
What
if I voted for L&B’s nominees but want to change my vote after I returned the [COLOR] proxy?
If
you have already voted using a [COLOR] proxy card sent to you by L&B, you have every right to change it and we urge you to
revoke that proxy by voting in favor of our Board of Trustees’ nominees by using and submitting the enclosed WHITE proxy
card, by voting beforehand by Internet or telephone, by attending the Annual Meeting in person via webcast or by notifying our
Secretary beforehand. Only the latest validly executed proxy that you submit will be counted.
What happens to any proxy voting authority I granted
in favor of L&B’s shareholder nominees if L&B abandons its solicitation?
If L&B abandons its solicitation,
withdraws its nominees or the L&B shareholder nominees are otherwise disqualified from election, and you previously authorized a proxy
to vote in favor of the L&B nominees, your proxy will not be exercised and your votes will not be cast for the L&B nominees. If
you wish to vote for the remaining nominees named in this proxy statement, you may authorize a new proxy by submitting the enclosed WHITE
proxy card or by authorizing a proxy to vote by Internet or telephone, or you may attend the Annual Meeting and vote in person via webcast.
Only the latest validly executed proxy that you submit will be counted.
In
addition, if the number of nominees no longer exceeds the number of trustees to be elected, trustees will no longer be elected
by a plurality of the votes, but will instead be elected by a majority of the votes cast,
meaning
the number of votes cast “FOR” each nominee must exceed the number of votes “WITHHELD” for such nominee.
Will
anyone contact me regarding this vote?
It
is contemplated that brokerage houses will forward the proxy materials to Shareholders at our request. In addition to the
solicitation of proxies by use of the mail, our trustees, officers, and other employees may solicit proxies by telephone,
facsimile, e-mail, or personal interviews without additional compensation. We may, from time to time, engage and pay outside
proxy solicitation firms, although we have not engaged an outside firm at this time.
Who
has paid for this proxy solicitation?
We
will bear the cost of preparing, printing, assembling and mailing the Notice, WHITE proxy card, proxy statement, and other materials
that may be sent to Shareholders in connection with this solicitation. We may also reimburse brokerage houses and other custodians,
nominees, and fiduciaries for their expenses incurred in forwarding solicitation materials to the beneficial owners of shares
held of record by such persons.
We have also retained D.F. King
& Co., Inc. to act as proxy solicitor. Under our agreement with D.F. King & Co., Inc., they will receive a fee estimated not to
exceed $600,000 plus the reimbursement of reasonable expenses. D.F. King & Co., Inc. expects that approximately 40 of their employees
will assist in the solicitation.
Shareholder Nominees at the Annual Meeting
L&B, a shareholder of the
Trust, which is reported to beneficially own (as of the close of business on the Record Date) approximately 2.3% of our shares, has notified
the Trust of its intent to nominate two nominees for election as trustees at the Annual Meeting in opposition to our Board of Trustee’s
recommended nominees. Our Board of Trustees does not endorse any L&B shareholder nominee and unanimously recommends that you vote
FOR the election of each of the nominees proposed by the Board of Trustees by using the enclosed WHITE proxy card. The Board of Trustees
urges you not to sign or return any [COLOR] proxy card sent to you by L&B.
How do I submit a proposal for the 2023 Annual
Meeting of Shareholders?
If you wish to submit a shareholder
proposal pursuant to Rule 14a-8 under the Securities Exchange Act of 1934, as amended, which we refer to as the Exchange Act, or a trustee
nominee under the “proxy access” provisions of our bylaws for inclusion in our proxy statement and proxy card for our 2023
Annual Meeting of Shareholders, you must submit the proposal to our Secretary no later than December 12, 2022 or submit the trustee nominee
between November 12, 2022 and December 12, 2022, in accordance with Rule 14a-8 and our bylaws. In addition, any shareholder who wishes
to propose a nominee to our Board of Trustees or submit any other matter to a vote at the 2023 Annual Meeting of Shareholders (other than
a shareholder proposal included in our proxy materials pursuant to Rule 14a-8 under the Exchange Act) must deliver such information to
our Secretary no later than December 12, 2022 (or as otherwise provided by applicable laws and in our bylaws, which are on file with the
SEC and may be obtained from our Secretary upon request).
Our
Board of Trustees will review any shareholder proposals that are timely submitted and will determine whether such proposals meet
the criteria for inclusion in the proxy solicitation materials or for consideration at the 2023 Annual Meeting of Shareholders.
What
does it mean if I receive more than one WHITE proxy card?
It
means that you have multiple accounts at the transfer agent and/or with brokers. Please complete and return all WHITE proxy cards
to ensure that all your shares are voted.
Can
I find additional information on the Company’s web site?
Yes.
Our web site is located at www.lxp.com. Although the information contained on our web
site is not part of this proxy statement, you can view additional information on the web site, such as our code of business conduct
and ethics, corporate governance guidelines, charters of board committees, and reports that we file and furnish with the SEC.
Copies of our code of business conduct and ethics, corporate governance guidelines, and charters of board committees also may
be obtained by written request addressed to (1) LXP Industrial Trust, One Penn Plaza, Suite 4015, New York, New York 10119-4015,
Attention: Investor Relations or (2) ir@lxp.com.
How
do I obtain a copy of the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 from the Company?
Upon
written request to (1) LXP Industrial Trust, One Penn Plaza, Suite 4015, New York, NY 10119-4105, Attention: Investor Relations
or (2) ir@lxp.com, we will provide any shareholder, without charge, a hardcopy of our Annual
Report on Form 10-K for the year ended December 31, 2021 filed with the SEC, including our financial statements and schedule,
but without exhibits. You may also obtain our Annual Report to Shareholders, which includes our Annual Report on Form 10-K, at
www.envisionreports.com/LXP.
What
is “householding”?
“Householding”
allows companies to deliver only one copy of notices and other proxy materials to multiple shareholders who share the same address
(if they appear to be members of the same family) unless the company has received contrary instructions from an affected shareholder.
We do not offer “householding” for shareholders of record. Please contact your broker if you are not a shareholder
of record to find out if your broker offers “householding.”
* If requesting materials by
e-mail, please send an e-mail with “Proxy Materials LXP Industrial Trust” in the subject line. Include your full name
and address, plus the number located in the shaded bar on the reverse side of the Notice of Proxy, and state that you want a paper
copy of the meeting materials. Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to
your investment advisor.
Appendix
A
LXP
INdustrial Trust
ARTICLES
OF AMENDMENT
THIS
IS TO CERTIFY THAT:
FIRST:
The Amended and Restated Declaration of Trust of LXP Industrial Trust, a Maryland real estate investment trust (the “Trust”),
is hereby amended by deleting existing Article SIXTH (a) in its entirety and substituting in lieu thereof a new article to read
as follows:
SIXTH: (a) The
total number of shares of beneficial interest of all classes which the Trust has the authority to issue is 1,400,000,000 shares
of beneficial interest, par value $.0001 per share, of which 600,000,000 shares are classified as “Common Stock,”
700,000,000 shares are classified as “Excess Stock” and 100,000,000 shares are classified as “Preferred Stock”
(of which 3,100,000 shares are classified as “6.50% Series C Cumulative Convertible Preferred Stock” (“Series
C Preferred Shares”)). The Board of Trustees may classify and reclassify any unissued shares of beneficial interest by setting
or changing, in any one or more respects, the preferences, conversion or other rights, voting powers, restrictions, limitations
as to dividends, qualifications or terms or conditions of redemption of such shares of beneficial interest.
SECOND:
The amendment to the declaration of trust of the Trust as set forth above has been duly advised by the Board of Trustees and approved
by the shareholders of the Trust as required by law and the declaration of trust and bylaws of the Trust.
THIRD:
Immediately prior to the above amendment, the Trust had authority to issue 1,000,000,000 shares of beneficial interest, par value
$.0001 per share, of which 400,000,000 were classified as “Common Stock,” 500,000,000 were classified as “Excess
Stock” and 100,000,000 were classified as “Preferred Stock,” of which 3,100,000 shares were classified as “6.50%
Series C Cumulative Convertible Preferred Stock.” The aggregate par value of all shares of all classes or series of beneficial
interest of the Trust was $100,000.
FOURTH:
The total number of shares of beneficial interest which the Trust has authority to issue pursuant to the foregoing amendment is
1,400,000,000 shares of beneficial interest, par value $.0001 per share, of which 600,000,000 shares are classified as “Common
Stock,” 700,000,000 shares are classified as “Excess Stock” and 100,000,000 shares are classified as “Preferred
Stock,” of which 3,100,000 shares are classified as “6.50% Series C Cumulative Convertible Preferred Stock.”
The aggregate par value of all shares of all classes or series of beneficial interest of the Trust is $140,000.
FIFTH:
The preferences, conversion and other rights, voting powers, restrictions, limitations as to dividends, qualifications, and terms
and conditions of redemption of any class or series of shares of beneficial interest of the Trust were not changed by the foregoing
amendment of the declaration of trust.
SIXTH:
These Articles of Amendment shall become effective at __:__ [a][p].m., Eastern Time, on _______________, 2022.
SEVENTH:
The undersigned acknowledges these Articles of Amendment to be the trust act of the Trust and, as to all matters or facts required
to be verified under oath, the undersigned acknowledges that, to the best of his knowledge, information and belief, these matters
and facts are true in all material respects and that this statement is made under the penalties of perjury.
IN
WITNESS WHEREOF, the Trust has caused these Articles of Amendment to be signed in its name and on its behalf by the below its
_____________________ and attested to by its _____________ on this __ day of ______________, 2022.
ATTEST: |
|
|
LXP INDUSTRIAL
TRUST |
|
|
|
|
|
|
|
|
|
|
By: |
|
(SEAL) |
|
Name: |
|
|
Name: |
|
|
Title: |
|
|
Title: |
|
|
Appendix
B
LXP
INDUSTRIAL TRUST
2022 EQUITY-BASED AWARD PLAN
Plan
Document
1. Introduction.
(a) Purpose.
By resolution of the Compensation Committee of its Board of Trustees approved on April 1, 2022 (the “Committee Approval
Date”), LXP Industrial Trust (the “Company”) hereby establishes this equity-based incentive
compensation plan to be known as the “LXP Industrial Trust 2022 Equity-Based Award Plan” (the “Plan”).
The Plan was established for the following purposes: (i) to enhance the Company’s ability to attract highly qualified
personnel; (ii) to strengthen its retention capabilities; (iii) to enhance the long-term performance and competitiveness
of the Company; and (iv) to ensure that the interests of Plan participants align with those of the Company’s shareholders.
This Plan is intended to achieve such purposes and to serve as the sole source for all future equity-based awards to those eligible
for Plan participation.
(b) Effective
Date. This Plan shall become effective on the date (the “Effective Date”) upon which it has received
approval by a vote of a majority of the votes cast at a duly held meeting of the Company’s shareholders (or by such other
shareholder vote that the Committee determines to be sufficient for the issuance of Shares and Awards according to the Company’s
governing documents and Applicable Law).
(c) Definitions.
Terms used herein and in Appendix I that begin with an initial capital letter shall have the meanings set forth in
Appendix I or elsewhere in this Plan, unless the context of their use clearly indicates a different meaning.
(d) Effect
on Other Plans, Awards, and Arrangements. This Plan is not intended to affect, and shall not affect, any share options, equity-based
compensation, or other benefits that the Company or its Affiliates may have provided, or may provide in the future, pursuant to any agreement,
plan, or program that is independent of this Plan. For example, changes in this Plan from the Company’s Amended and Restated 2011
Equity-Based Award Plan (the “2011 Plan” do not affect any awards granted under the 2011 Plan.
2. Types
of Awards. The Plan permits, but does not require, the granting of the following types of Awards according to the Sections
of the Plan listed below:
Section 5 |
Share
Options |
Section 6 |
Shares
Appreciation Rights (“SARs”) Restricted Share, Restricted Share
Unit (“RSUs”) and Unrestricted Share |
Section 7 |
Awards |
Section 8 |
Performance
Awards |
Section 9 |
Dividends
Equivalent Rights |
3. Shares
Available for Awards.
(a) Generally.
Subject to Section 12 below, from the Effective Date, a total of 4,000,000 Shares shall be available for issuance under the
Plan (plus any shares subject to outstanding awards under the Amended and Restated
Lexington Realty Trust 2011 Equity-Based Award Plan). The Shares deliverable pursuant to Awards shall be authorized but unissued Shares, or Shares that the Company otherwise
holds in treasury or in trust.
(b) Replenishment;
Counting of Shares. If an Award expires or becomes un-exercisable without having been exercised in full or, with respect to
Restricted Shares, Restricted Share Units, or Performance Units, is forfeited to the Company, the unpurchased Shares (or for Awards
other than Options or SARs, the forfeited
Shares)
which were subject thereto will become available for future grant or sale under this Plan, unless this Plan has terminated.
With respect to SARs, all of the Shares covered by the Award (that is, Shares actually issued pursuant to a SAR, as well as
the Shares that represent payment of the exercise price therefor) will cease to be available under this Plan. Shares that
actually have been issued under this Plan under any Award will not revert to this Plan and will not become available for
future distribution under this Plan; provided, however, that if Shares issued pursuant to Awards of Restricted Shares are
forfeited to the Company, such Shares will become available for future grant under this Plan. Shares: (i) used to pay
the exercise price of an Award, (ii) used to satisfy the Withholding Tax obligations related to an Award, or
(iii) re-acquired by the Company on the open market or otherwise using cash proceeds from the exercise of Options will
be deemed used under this Plan and will not become available for future grant or sale under this Plan. To the extent that an
Award under this Plan is paid out in cash rather than Shares, such cash payment will not result in reducing the number of
Shares available for issuance under this Plan. Notwithstanding the foregoing, and subject to adjustment as provided in
Section 13, the maximum number of Shares that may be issued upon the exercise of ISOs will equal the aggregate Share
number stated in Section 3(a), plus, to the extent allowable under Code Section 422, any Shares that become
available for issuance under this Plan pursuant to this Section 3(b).
4. Eligibility.
(a) General
Rule. Subject to the express provisions of the Plan, the Committee shall determine from the class of Eligible Persons those
Persons to whom Awards may be granted, the number of Shares subject to each Award, the price (if any) to be paid for the Shares
or the Award and, in the case of Performance Awards, in addition to matters discussed in Section 8 below, the specific objectives,
goals and performance criteria that further define the Performance Award. The Committee may grant ISOs only to Employees of the
Company or any of its Affiliates that is a “parent corporation” or “subsidiary corporation” within the
meaning of Section 424 of the Code, and may grant all other Awards to any Eligible Person. A Participant who has been granted
an Award may be granted an additional Award or Awards in accordance with the terms of this Plan if the Committee shall so determine,
if such person is otherwise an Eligible Person.
(b) Documentation
of Award. Each Award shall be evidenced by an Award Agreement signed by the Company and by the Participant. The Award Agreement
shall set forth the material terms and conditions of the Award established by the Committee, and each Award shall be subject to
the terms and conditions set forth in Sections 13, 22 and 23 unless otherwise specifically provided in an Award Agreement.
(c) Minimum
Vesting for Awards. Notwithstanding any other provision of this Plan to the contrary, Awards that are subject to vesting shall
become vested on a pro rata basis over a period of not less than one year following the Date of Grant; provided, however, that,
notwithstanding the foregoing, such Awards that result in the issuance of an aggregate of up to 5% of the maximum number
of Shares available at any time pursuant to Section 3(a) may be granted without respect to such minimum vesting provision.
(d) Limitation
on Individual Grants. The maximum number of Shares subject to an Award or Awards granted to any one Participant in any one
calendar year may not exceed 500,000 Shares (or 75,000 Shares for non-Employee Trustee), subject to adjustment as provided in Section
12.
5. Share
Options.
(a) Grants.
Subject to the special rules for ISOs set forth in the next paragraph, the Committee may grant Options to Eligible Persons pursuant
to Award Agreements (i) that set forth terms and conditions that are not inconsistent with the Plan, that may be immediately
exercisable or that may become exercisable in whole or in part based on future events or conditions, (ii) that may include
vesting or other requirements for the right to exercise
the Options, and (iii) that may differ for any reason from those
granted to other Eligible Persons or classes of Eligible Persons, provided in all instances that:
(A) the
exercise price for Shares subject to purchase through exercise of an Option shall not be less than 100% of the Fair Market
Value of the underlying Shares on the Grant Date; and
(B) no
Option shall be exercisable for a term ending more than ten years after the Grant Date for such Option.
(b) Special
ISO Provisions. The following provisions shall control any grants of Options that are denominated as ISOs; provided that
ISOs may not be awarded unless the Plan receives shareholder approval within twelve (12) months after its Committee
Approval Date, and provided further that ISOs may not be granted more than ten (10) years after the Board approves the
Plan.
(i) Eligibility.
The Committee may grant ISOs only to Employees of the Company or any of its Affiliates that is a “parent corporation”
or “subsidiary corporation” within the meaning of Code Section 424.
(ii) Documentation.
Each Option that is intended to be an ISO must be designated as an ISO in the Award Agreement, provided that any Option that is
designated as an ISO will not be an ISO to the extent that such Option fails to meet the requirements of Code Section 422
or the provisions of this Section 5(b). In the case of an ISO, the Committee shall determine on the Grant Date the acceptable
methods of paying the exercise price for Shares and shall include such methods in the applicable Award Agreement.
(iii) $100,000
Limit. To the extent that the aggregate Fair Market Value of Shares with respect to which ISOs first become exercisable by
a Participant in any calendar year (including those granted under this Plan and any other plan of the Company or any of its Affiliates)
exceeds U.S. $100,000, such excess Options shall be treated as Non-ISOs. For purposes of determining whether the U.S. $100,000
limit is exceeded, the Fair Market Value of the Shares subject to an ISO shall be determined as of the Grant Date. In reducing
the number of Options treated as ISOs to meet the U.S. $100,000 limit, the most recently granted Options shall be reduced
first. In the event that Code Section 422 is amended to alter the limitation set forth therein, the limitation of this paragraph
shall be automatically adjusted accordingly.
(iv) Grants
to 10% Holders. In the case of an ISO granted to an Employee who is a Ten Percent Holder on the Grant Date, the ISO’s
term shall not exceed five (5) years from the Grant Date, and the exercise price shall be at least 110% of the Fair
Market Value of the underlying Shares as of the Grant Date. In the event that Code Section 422 is amended to alter the limitations
set forth therein, the limitation of this paragraph shall be automatically adjusted accordingly.
(v) Substitution
of Options. In the event that the Company or its Affiliate acquires (whether by purchase, merger, or otherwise) all or substantially
all of the outstanding capital stock or assets of another corporation, or in the event of any reorganization or other transaction
qualifying under Code Section 424, the Committee may, in accordance with the provisions of Code Section 424, substitute
ISOs for ISOs previously granted under the plan of the acquired company provided (A) the excess of the aggregate Fair Market
Value of the Shares subject to an ISO immediately after the substitution over the aggregate exercise price of such Shares is not
more than the similar excess immediately before such substitution, and (B) the new ISO does not give additional benefits
to the Participant, including any extension of the exercise period.
(vi) Notice
of Disqualifying Dispositions. By executing an Award Agreement for ISOs, each Participant agrees to notify the Company in
writing immediately after the Participant sells, transfers or otherwise disposes of any Shares acquired through exercise of the
ISO, if such disposition occurs within the earlier of (A) two years of the Grant Date, or (B) one (1) year after
the exercise of the ISO being exercised. Each Participant further agrees to provide any information about a disposition of Shares
as may be requested by the Company from time to time.
(c) Method
of Exercise. Each Option may be exercised, in whole or in part (provided, that the Company shall not be required to issue
fractional Shares) at any time and from time to time prior to its expiration, but only pursuant to the terms of the applicable
Award Agreement and subject to the times, circumstances, and conditions for exercise contained in the applicable Award Agreement.
Exercise shall occur by delivery of both written notice of exercise to a designated Employee of the Company and payment of the
full exercise price for the Shares being purchased. Unless otherwise specified in an Award Agreement, the exercise price of Options
held by any Participant shall be satisfied through a net exercise by surrendering to the Company Shares otherwise receivable upon
exercise of the Option having a Fair Market Value on the date of exercise equal to the aggregate exercise price of the Shares
as to which the Option is being exercised.
The
Company shall not deliver Shares pursuant to the exercise of an Option until the Company has received sufficient Shares (and/or
funds to the extent otherwise permitted pursuant to any Award Agreement) to cover the full exercise price due and all applicable
Withholding Taxes required by reason of such exercise.
Notwithstanding
any other provision of the Plan to the contrary, no Participant who is a Trustee or an “executive officer” of the
Company within the meaning of Section 13(k) of the Exchange Act shall be permitted to make payment with respect to any Awards
granted under the Plan, or to continue any extension of credit with respect to such payment, with a loan from the Company or a
loan arranged by the Company in violation of Section 13(k) of the Exchange Act.
(d) Exercise
of an Unvested Option. Unvested Options shall not be exercisable by the Participant.
(e) Termination
of Continuous Service. The Committee may establish and set forth in the applicable Award Agreement or employment- related
agreements the terms and conditions on which an Option shall remain exercisable, if at all, following termination of a Participant’s
Continuous Service. The Committee may waive or modify these provisions at any time. To the extent that a Participant is not entitled
to exercise an Option at the date of his or her termination of Continuous Service, or if the Participant (or other person entitled
to exercise the Option) does not exercise the Option to the extent so entitled within the time specified in the Award Agreement,
the relevant employment-related agreements or below (as applicable), the Option shall terminate, and the Shares underlying the
unexercised portion of the Option shall revert to the Plan and become available for future Awards. In no event may any Option
be exercised after the expiration of the Option term as set forth in the Award Agreement.
The
following provisions shall apply to the extent an Award Agreement or an employment-related agreement does not specify the terms
and conditions upon which an Option shall terminate when there is a termination of a Participant’s Continuous Service:
Reason
for terminating Continuous Service |
|
Option
Termination Date |
|
|
|
By
the Company for Cause, or what would have been Cause if the Company had known all of the relevant facts. |
|
Termination
of the Participant’s Continuous Service, or when Cause first existed, if earlier. |
Disability
of the Participant. |
|
Within
six (6) months after termination of the Participant’s Continuous Service. |
Retirement
of the Participant. |
|
Within
six (6) months (three (3) months in the case of ISOs) after termination of the Participant’s Continuous Service. |
Death
of the Participant during Continuous Service or within ninety (90) days thereafter. |
|
Within
six (6) months after termination of the Participant’s Continuous Service. |
Any
other reason. |
|
Within
ninety (90) days after termination of the Participant’s Continuous Service. |
If
there is a Securities and Exchange Commission blackout period (or a Company-imposed blackout period) that prohibits the buying
or selling of Shares during any part of the ten (10)-day period before the expiration of any Option based on the termination of
a Participant’s Continuous Service (as described above), the period for exercising the Options shall be extended until ten
(10) days beyond when such blackout period ends.
Notwithstanding
any provision herein or within an Award Agreement, no Option shall ever be exercisable after the expiration date of its original
term as set forth in the Award Agreement.
6. SARS.
(a) Grants.
The Committee may grant SARs to Eligible Persons pursuant to Award Agreements setting forth terms and conditions that are not
inconsistent with the Plan; provided that:
(i) the
exercise price for the Shares subject to each SAR shall not be less than the Fair Market Value of the underlying Shares as of
the Grant Date (unless the Award replaces a previously issued Option or SAR);
(ii) no
SAR shall be exercisable for a term ending more than ten (10) years after its Grant Date; and
(iii) each
SAR shall, except to the extent that an Award Agreement for an SAR (an “SAR Award Agreement”) provides
otherwise, be subject to the provisions of Section 5(e) relating to the effect of a termination of Participant’s Continuous
Service, with “SAR” being substituted for “Option.”
(b) Settlement.
Subject to the Plan’s terms, a SAR shall entitle the Participant, upon exercise of the SAR, to receive Shares having a Fair
Market Value on the date of exercise equal to the product of the number of Shares as to which the SAR is being exercised, and
the excess of (i) the Fair Market Value, on such date, of the Shares covered by the exercised SAR, over (ii) an exercise
price designated in the SAR Award Agreement. Notwithstanding the foregoing, a SAR Award Agreement may limit the total settlement
value that the Participant will be entitled to receive upon the SAR’s exercise, and may provide for settlement either in
cash or in any combination of cash or Shares that the Committee may authorize pursuant to an Award Agreement. If, on the date
on which a SAR or portion thereof is to expire, the Fair Market Value of the underlying Shares exceeds their aggregate exercise
price of such SAR, then the SAR shall be deemed exercised, and the Participant shall within ten (10) days thereafter receive
the Shares that would have been issued on such date if the Participant had affirmatively exercised the SAR on that date.
(c) SARs
related to Options. The Committee may grant SARs either concurrently with the grant of an Option or with respect to an outstanding
Option, in which case the SAR shall extend to all or a portion of the Shares covered by the related Option, and shall have an
exercise price that is not less than the exercise price of the related Option. A SAR shall entitle the Participant who holds the
related Option, upon exercise of the SAR and surrender of the related Option, or portion thereof, to the extent that the SAR and
related Option each were previously unexercised, to receive payment of an amount determined pursuant to Section 6(b) above.
Any SAR granted in tandem with an ISO will contain such terms as may be required to comply with the provisions of Code Section 422.
(d) Effect
on Available Shares. All SARs that may be settled in Shares shall be counted in full against the number of Shares available
for award under the Plan, regardless of the number of Shares actually issued upon settlement of the SARs.
7. Restricted
Shares, RSUs, and Unrestricted Share Awards.
(a) Grant.
The Committee may grant Restricted Share, RSU, or Unrestricted Share Awards to Eligible Persons, in all cases pursuant to Award
Agreements setting forth terms and conditions that are not inconsistent with the Plan. The Committee shall establish as to each
Restricted Share or RSU Award the number of Shares deliverable or subject to the Award (which number may be determined by a written
formula), and the period
or
periods of time (the “Restriction Period”) at the end of which all or some restrictions specified
in the Award Agreement shall lapse, and the Participant shall receive unrestricted Shares (and cash to the extent provided in
the Award Agreement) in settlement of the Award. Such restrictions may include, without limitation, restrictions concerning
dividend and voting rights and transferability, and such restrictions may lapse separately or in combination at such times
and pursuant to such circumstances or based on such criteria as selected by the Committee, including, without limitation,
criteria based on the Participant’s duration of employment, directorship or consultancy with the Company, individual,
group, or divisional performance criteria, Company performance, or other criteria selection by the Committee. The Committee
may make Restricted Share and RSU Awards with or without the requirement for payment of cash or other consideration. In
addition, the Committee may grant Awards hereunder in the form of Unrestricted Shares which shall vest in full upon the Grant
Date or such other date as the Committee may determine or which the Committee may issue pursuant to any program under which
one or more Eligible Persons (selected by the Committee in its sole discretion) elect to pay for such Shares or to receive
Unrestricted Shares in lieu of cash bonuses that would otherwise be paid.
(b) Vesting
and Forfeiture. The Committee shall set forth, in an Award Agreement granting Restricted Shares or RSUs, the terms and conditions
under which the Participant’s interest in the Restricted Shares or the Shares subject to RSUs will become vested and non-forfeitable.
Except as set forth in the applicable Award Agreement or in employment-related agreements or as the Committee otherwise determines,
upon termination of a Participant’s Continuous Service for any reason, the Participant shall forfeit his or her Restricted
Shares and RSUs to the extent the Participant’s interest therein has not vested on or before such termination date; provided
that if a Participant purchases Restricted Shares and forfeits them for any reason, the Company shall return the purchase price
to the Participant to the extent either set forth in an Award Agreement or required by Applicable Laws.
(c) Account
for Restricted Shares. Unless otherwise provided in an Award Agreement, the Company shall hold Restricted Shares in a book-entry
restricted account until the restrictions on such Shares lapse, and the Participant shall provide the Company with appropriate
stock powers endorsed in blank. The Participant’s failure to provide such stock powers within ten (10) days after receiving
a written request from the Company therefor shall entitle the Committee to unilaterally declare a forfeiture of all or some of
the Participant’s Restricted Shares.
(d) Section 83(b)
Elections. A Participant may make an election under Code Section 83(b) (the “Section 83(b) Election”)
with respect to Restricted Shares. A Participant who has received RSUs may, within ten (10) days after receiving the RSU
Award, provide the Committee with a written notice of his or her desire to make Section 83(b) Election with respect to the
Shares subject to such RSUs. The Committee may in its discretion convert the Participant’s RSUs into Restricted Shares,
on a one- for-one basis, in full satisfaction of the Participant’s RSU Award. The Participant may then make a Section 83(b)
Election with respect to those Restricted Shares; provided that the Participant’s Section 83(b) Election will be invalid
if not filed with the Company and the appropriate U.S. tax authorities within 30 days after the Grant Date of the
RSUs that are thereafter replaced by the Restricted Shares.
(e) Issuance
of Shares upon Vesting. As soon as practicable after vesting of a Participant’s Restricted Shares (or of the right to
receive Shares underlying RSUs), the Company shall deliver to the Participant, free from vesting restrictions, one Share for each
surrendered and vested Restricted Share (or deliver one Share free of the vesting restriction for each vested RSU), unless an
Award Agreement provides otherwise and subject to Section 10 regarding Withholding Taxes. No fractional Shares shall be distributed,
and cash shall be paid in lieu thereof.
8. Performance
Awards.
(a) Grant.
The Committee is hereby authorized to grant Performance Awards to Participants. Performance Awards include arrangements under
which the grant, issuance, retention, vesting and/or transferability of any Award are subject to Performance Criteria and such
additional conditions or terms as the Committee may
designate. Subject to the terms of the Plan and any applicable Award Agreement,
a Performance Award granted under the Plan:
(i) may
be denominated or payable in cash, Shares (including, without limitation, Restricted Shares), other securities, or other Awards;
and
(ii) shall
confer on the holder thereof rights valued as determined by the Committee and payable to, or exercisable by, the holder of the
Performance Award, in whole or in part, on the achievement of such performance goals during such Performance Periods as the Committee
shall establish.
(b) Amendment
of Performance Criteria. After a Performance Award has been granted, the Committee may, if it determines appropriate,
amend any Performance Criteria, at its sole and absolute discretion.
(c) Satisfaction
of Performance Criteria. If, as a result of the applicable Performance Criteria being met, a Performance Award becomes
vested and/or exercisable in respect of some, but not all of the number of Shares underlying such Award, which did not become
vested and exercisable by the end of the Performance Period, such Performance Award shall thereupon lapse and cease to be exercisable
in respect of the balance of the Shares which did not vest and/or become exercisable by the end of the Performance Period.
9. Dividend
Equivalent Rights. The Committee may grant Dividend Equivalent Rights to any Eligible Person, and may do so either pursuant
to an Award Agreement that is independent of any other Award (other than an Option or SAR) or through a provision in another Award
that Dividend Equivalent Rights attach to the Shares underlying the Award. For example, and without limitation, the Committee
may grant a Dividend Equivalent Right in respect of each Share subject to a Restricted Share Award, RSU Award, or Performance
Award.
(a) Nature
of Right. Each Dividend Equivalent Right shall represent the right to receive amounts based on the dividends declared on Shares
as of all dividend payment dates during the term of the Dividend Equivalent Right (as determined by the Committee). Unless otherwise
determined by the Committee, a Dividend Equivalent Right shall expire upon termination of the Participant’s Continuous Service,
provided that a Dividend Equivalent Right that is granted as part of another Award shall have a term and an expiration date that
coincides with those of the related Award.
(b) Settlement.
Unless otherwise provided in an Award Agreement, Dividend Equivalent Rights shall be paid out on the (i) record date for
dividends if the Award occurs on a stand-alone basis, and (ii) vesting or later settlement date for another Award if the
Dividend Equivalent Right is granted as part of it. Payment of all amounts determined in accordance with this Section shall be
in Shares, with cash paid in lieu of fractional Shares, provided that the Committee may instead provide in an Award Agreement
for cash settlement of all or part of the Dividend Equivalent Rights. Only the Shares actually issued pursuant to Dividend Equivalent
Rights shall count against the limits set forth in Section 3 above.
(c) Other
Terms. The Committee may impose such other terms and conditions on the grant of a Dividend Equivalent Right as it deems appropriate
in its discretion as reflected by the terms of the Award Agreement. The Committee may establish a program under which Dividend
Equivalent Rights may be granted in conjunction with other Awards.
10. Taxes;
Withholding.
(a) General
Rule. Participants are solely responsible and liable for the satisfaction of all taxes and penalties that may arise in connection
with Awards, and neither the Company or any of its Affiliates, nor any of their respective employees, directors, or agents shall
have any obligation to mitigate, indemnify, or otherwise hold any Participant harmless from any or all of such taxes. The Company’s
obligation to deliver Shares (or to pay cash) to Participants pursuant to Awards is at all times subject to a Participant’s
prior or coincident satisfaction of all required
Withholding Taxes. Except to the extent otherwise either provided in an Award
Agreement, the Company or any of its Affiliates shall satisfy Withholding Taxes:
(i) first
by withholding and cancelling the Participant’s rights with respect to a number of Shares that (A) would otherwise
have been delivered to the Participant pursuant to the Award, and (B) have an aggregate Fair Market Value (as of the date
of withholding) equal to the Withholding Taxes;
(ii) second
by withholding any cash otherwise payable to the Participant pursuant to the Award; and
(iii) finally,
by withholding the cash otherwise payable to the Participant by the Company.
The
number of Shares withheld and cancelled to pay a Participant’s Withholding Taxes shall not be rounded up to the
nearest whole Share sufficient to satisfy such taxes. In such case, the Participant shall pay to the Company that amount of
cash that is equal to the amount by which the Withholding Taxes exceed the Fair Market Value of such Shares as of the date of
withholding.
(b) U.S. Code
Section 409A. To the extent that the Committee determines that any Award granted under the Plan is subject to Code Section 409A,
the Award Agreement evidencing such Award shall incorporate the terms and conditions required by Code Section 409A. To the
extent applicable, the Plan and any Award Agreements shall be interpreted in accordance with Code Section 409A and Department
of Treasury regulations and other interpretive guidance issued thereunder, including, without limitation, any such regulations
or other guidance that may be issued after the Effective Date. Notwithstanding any provision of the Plan to the contrary, the
Committee may adopt such amendments to the Plan and the applicable Award Agreement or adopt other policies and procedures (including
amendments, policies and procedures with retroactive effect), or take any other actions, that the Committee determines are necessary
or appropriate (i) to exempt the Award from Code Section 409A and/or preserve the intended tax treatment of the benefits
provided with respect to the Award, or (ii) to comply with the requirements of Code Section 409A and related Department
of Treasury guidance and thereby avoid the application of any penalty taxes under such Section.
(c) Unfunded
Tax Status. The Plan is intended to be an “unfunded” plan for incentive compensation. With respect to any payments
not yet made to a Person pursuant to an Award, nothing contained in the Plan or any Award Agreement shall give such Person any
rights that are greater than those of a general creditor of the Company or any of its Affiliates, and a Participant’s rights
under the Plan at all times constitute an unsecured claim against the general assets of the Company for the collection of benefits
as they come due. Neither the Participant nor the Participant’s duly- authorized transferee or Beneficiaries shall have
any claim against or rights in any specific assets, Shares, or other funds of the Company.
11. Non-Transferability
of Awards.
(a) General.
Except as set forth in this Section, or as otherwise approved by the Committee, Awards may not be sold, pledged, assigned, hypothecated,
transferred, or disposed of in any manner other than by will or by the laws of descent or distribution. The designation of a death
Beneficiary by a Participant will not constitute a transfer. An Award may be exercised during the lifetime of the holder of an
Award only by such holder, by the duly-authorized legal representative of a holder who is Disabled, or by a transferee permitted
by this Section.
(b) Limited
Transferability Rights. The Committee may in its discretion provide in an Award Agreement that an Award in the form of a non-ISO,
SAR, Restricted Shares, or Performance Shares may be transferred, on such terms and conditions as the Committee deems appropriate,
either (i) by instrument to the Participant’s Immediate Family, (ii) by instrument to an inter vivos or testamentary
trust (or other entity) in which the Award is to be passed to the Participant’s designated beneficiaries, or (iii) by
gift to charitable institutions. Any transferee of the Participant’s rights shall succeed and be subject to all of the terms
of the applicable Award Agreement and the Plan.
(c) Death.
In the event of the death of a Participant, any outstanding Awards issued to the Participant shall automatically be transferred
to the Participant’s Beneficiary (or, if no Beneficiary is designated or surviving, to the person or persons to whom the
Participant’s rights under the Award pass by will or the laws of descent and distribution).
12. Change
in Capital Structure; Change in Control; Etc.
(a) Changes
in Capitalization. The Committee shall equitably adjust the number of Shares covered by each outstanding Award, and the number
of Shares that have been authorized for issuance under the Plan but as to which no Awards have yet been granted or that have been
returned to the Plan upon cancellation, forfeiture, or expiration of an Award, the maximum annual Share limit on Awards to any
individual Participant, as well as the exercise or other price per Share covered by each such outstanding Award, to reflect any
increase or decrease in the number of issued Shares resulting from a stock-split, reverse stock-split, stock dividend, combination,
recapitalization or reclassification of the Shares, merger, consolidation, change in organization form, or any other increase or
decrease in the number of issued Shares effected without receipt of consideration by the Company. In the event of any such transaction
or event, the Committee may provide in substitution for any or all outstanding Awards such alternative consideration (including
cash or securities of any surviving entity) as it may in good faith determine to be equitable under the circumstances and may require
in connection therewith the surrender of all Awards so replaced. In any case, such substitution of cash or securities shall not
require the consent of any person who is granted Awards pursuant to the Plan. Except as expressly provided herein, or in an Award
Agreement, if the Company issues for consideration shares of stock of any class or securities convertible into shares of stock
of any class, the issuance shall not affect, and no adjustment by reason thereof shall be required to be made with respect to the
number or price of Shares subject to any Award.
(b) Dissolution
or Liquidation. In the event of the dissolution or liquidation of the Company other than as part of a Change of Control but
subject to the terms of any Award Agreements or employment-related agreements between the Company or any of its Affiliates and
any Participant, each Award will terminate immediately prior to the consummation of such dissolution or liquidation, subject to
the ability of the Committee to exercise any discretion authorized in the case of a Change in Control.
(c) Change
in Control. In the event of a Change in Control but subject to the terms of any Award Agreements or employment-related agreements
between the Company or any of its Affiliates and any Participant, each outstanding Award shall be assumed, or a substantially
equivalent award shall be substituted, by the surviving or successor company or a parent or subsidiary of such successor company
(in each case, the “Successor Company”) upon consummation of the Change in Control. Notwithstanding
the foregoing, instead of having outstanding Awards be assumed or replaced with equivalent awards by the Successor Company, the
Committee may in its sole and absolute discretion and authority, without obtaining the approval or consent of the Company’s
shareholders or any Participant with respect to his or her outstanding Awards, take one or more of the following actions (with
respect to any or all of the Awards, and with discretion to differentiate between individual Participants and Awards for any reason):
(i) accelerate
the vesting of Awards so that Awards shall vest (and, to the extent applicable, become exercisable) as to the Shares that otherwise
would have been unvested and provide that repurchase rights of the Company with respect to Shares issued pursuant to an Award
shall lapse as to the Shares subject to such repurchase right;
(ii) arrange
or otherwise provide for the payment of cash or other consideration to Participants in exchange for the satisfaction and cancellation
of all or some outstanding Awards (based on the Fair Market Value, as of the date of the Change in Control, of the Award being
cancelled, based on any reasonable valuation method selected by the Committee, and with the Committee having full discretion to
cancel either all Awards or only select Awards (such as only those that have vested on or before the Change in Control), provided,
that no payment of cash or other consideration shall be made for Options that have an exercise price in excess of Fair Market
Value;
(iii) terminate
all or some Awards upon the consummation of the Change in Control, provided that the Committee shall provide for vesting of such
Awards in full as of a date immediately prior to consummation of the Change in Control. To the extent that an Award is not exercised,
settled, or cancelled prior to
consummation of a transaction in which the Award is not being assumed or substituted, such Award
shall terminate upon such consummation; and/or
(iv) make
such other modifications, adjustments or amendments to outstanding Awards or this Plan as the Committee deems necessary or appropriate,
subject to the terms set forth above and Section 17.
Notwithstanding
the above and unless otherwise provided in an Award Agreement or in any employment-related agreement between the Company or any
of its Affiliates and the Participant, in the event a Participant is Involuntarily Terminated on or within twelve (12) months
(or any other period set forth in an Award Agreement) following a Change in Control, then any Award that is assumed or substituted
pursuant to this Section above shall accelerate and become fully vested (and become exercisable in full in the case of Options
and SARs), and any repurchase right applicable to any Shares underlying the Award shall lapse in full. The acceleration of vesting
and lapse of repurchase rights provided for in the previous sentence shall occur immediately prior to the effective date of the
Participant’s Involuntary Termination.
13. Recoupment
of Awards. Unless otherwise specifically provided in an Award Agreement, and to the extent permitted by Applicable Law,
the Committee may in its sole and absolute discretion, without obtaining the approval or consent of the Company’s shareholders
or of any Participant, require that any Participant reimburse the Company for all or any portion of any Awards granted under this
Plan (“Reimbursement”), or the Committee may require the termination of any outstanding, unexercised,
unexpired Awards (“Termination”), or rescission of any exercise, payment, or delivery pursuant to the
Award (“Rescission”), or the recapture of any Shares (“Recapture”), if and
to the extent:
(a) the
granting, vesting, or payment of such Award was predicated upon the achievement of certain financial results that were subsequently
the subject of a material financial restatement;
(b) in
the Committee’s view, the Participant either benefited from a calculation that later proved to be materially inaccurate,
or engaged in fraud or misconduct that caused or partially caused the need for a material financial restatement by the Company
or any Affiliate; and lower granting, vesting, or payment of such Award would have occurred based upon the conduct described in
clause (a) of this Section.
In
each instance, the Committee shall, to the extent practicable and allowable under Applicable Laws, require Reimbursement, Termination,
or Rescission of, or Recapture relating to, any such Award granted to a Participant; provided that the Company will not seek Reimbursement,
Termination, or Rescission of, or Recapture relating to, any such Awards that were paid or vested more than three (3) years
prior to the first date of the applicable restatement period. Notwithstanding any other provision of the Plan, all Awards shall
be subject to Reimbursement, Termination, Rescission, and/or Recapture to the extent required by Applicable Law, including but
not limited to Section 10D of the Exchange Act. In addition, without limiting anything in this Section 13, all Awards granted
under the Plan will be subject to recoupment in accordance with any clawback policy that the Company is required to adopt pursuant
to the listing standards of any national securities exchange or association on which the Company’s securities are listed
or as is otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other Applicable Law and any clawback
policy that the Company otherwise adopts, to the extent applicable and permissible under Applicable Law. In addition, the Board
may impose such other clawback, recovery or recoupment provisions in an Award Agreement as the Committee determines necessary
or appropriate, including but not limited to a reacquisition right in respect of previously acquired Shares or other cash or property
upon the occurrence of Cause. No recovery of compensation under such a clawback policy will be an event giving rise to a Participant’s
right to voluntarily terminate employment upon a “resignation for good reason,” or for a “constructive termination”
or any similar term under any plan of or agreement with the Company.
14. Relationship
to other Benefits. No payment pursuant to the Plan shall be taken into account in determining any benefits under any pension,
retirement, savings, profit sharing, group insurance, welfare, or other benefit plan of the Company or any of its Affiliates except
to the extent otherwise expressly provided in writing in such other plan or an agreement thereunder.
15. Administration
of the Plan. The Committee shall administer the Plan in accordance with its terms, provided that the Board may act in
lieu of the Committee on any matter. The Committee shall hold meetings at such times and places as it may determine from time
to time and may prescribe, amend, and rescind such rules, regulations, and procedures for the conduct of its business as it deems
advisable. In the absence of a duly appointed Committee, the Board shall function as the Committee for all purposes of the Plan.
(a) Committee
Composition. The Board shall appoint the members of the Committee. The Board may at any time appoint additional members to
the Committee, remove and replace members of the Committee with or without Cause, and fill vacancies on the Committee however
caused.
(b) Powers
of the Committee. Subject to the provisions of the Plan, the Committee shall have the authority, in its sole discretion:
(i) to
grant Awards and to determine Eligible Persons to whom Awards shall be granted from time to time and the number of Shares, units,
or dollars to be covered by each Award;
(ii) to
determine, from time to time, the Fair Market Value of Shares;
(iii) to
determine, and to set forth in Award Agreements, the terms and conditions of all Awards, including, but not limited to, any applicable
exercise or purchase price, the installments and conditions under which an Award shall become vested (which may be based on performance),
terminated, expired, cancelled, or replaced, and the circumstances for vesting acceleration or waiver of forfeiture restrictions,
and other restrictions and limitations;
(iv) to
approve the forms of Award Agreements and all other documents, notices, and certificates in connection therewith which need not
be identical either as to type of Award or among Participants;
(v) to
construe and interpret the terms of the Plan and any Award Agreement, to determine the meaning of their terms, and to prescribe,
amend, and rescind rules and procedures relating to the Plan and its administration;
(vi) to
the extent consistent with the purposes of the Plan and without amending the Plan, to modify, to cancel, or to waive the Company’s
rights with respect to any Awards, to adjust or to modify Award Agreements for changes in Applicable Law, and to recognize differences
in foreign law, tax policies, or customs;
(vii) to
require, as a condition precedent to the grant, vesting, exercise, settlement, and/or issuance of Shares pursuant to any Award,
that a Participant agree to execute a general release of claims (in any form that the Committee may require, in its sole discretion,
which form may include any other provisions (e.g. confidentiality and restrictions on competition) that are found in general
claims release agreements that the Company utilizes or expects to utilize);
(viii) in
the event that the Company establishes, for itself or using the services of a third party, an automated system for the documentation,
granting, settlement, or exercise of an Award, such as a system using an internet website or interactive voice response, to implement
paperless documentation, granting, settlement, or exercise of Awards by a Participant, may be permitted through the use of such
an automated system; and
(ix) to
make all interpretations and to take all other actions that the Committee may consider necessary or advisable to administer the
Plan or to effectuate its purposes.
Subject
to Applicable Law and the restrictions set forth in the Plan, the Committee may delegate administrative functions to individuals
who are Trustees or Employees.
(c) Local
Law Adjustments and Sub-Plans. To facilitate the making of any grant of an Award under this Plan, the Committee may adopt
rules and provide for such special terms for Awards to Participants who are (i) located within the United States, (ii) foreign
nationals, or (iii) employed by the Company or any of its Affiliates
outside of the United States of America as the Committee
may consider necessary or appropriate to accommodate differences in local law, tax policy, or custom. Without limiting the foregoing,
the Company is specifically authorized to adopt rules and procedures regarding local currency conversion, taxes, withholding procedures,
and handling of stock certificates, which vary with the customs and requirements of particular countries. The Company may adopt
sub-plans and establish escrow accounts and trusts, and settle Awards in cash in lieu of shares, as may be appropriate, required
or applicable to particular locations and countries.
(d) Action
by Committee. Unless otherwise established by the Board or in any charter of the Committee, a majority of the Committee shall
constitute a quorum, and the acts of a majority of the members present at any meeting at which a quorum is present, and acts approved
in writing by all members of the Committee in lieu of a meeting, shall be deemed the acts of the Committee. Each member of the
Committee is entitled to, in good faith, rely or act upon any report or other information furnished to that member by an officer
or other employee of the Company or any of its Affiliates, the Company’s independent certified public accounts, or any executive
compensation consultant or other professional retained by the Company to assist in the administration of the Plan.
(e) Deference
to Committee Determinations. The Committee shall have the discretion to interpret or construe ambiguous, unclear, or implied
(but omitted) terms in any fashion it deems to be appropriate in its sole discretion, and to make any findings of fact needed
in the administration of the Plan or Award Agreements. The Committee’s prior exercise of its discretionary authority shall
not obligate it to exercise its authority in a like fashion thereafter. The Committee’s interpretation and construction
of any provision of the Plan or of any Award or Award Agreement, and all determinations that the Committee makes pursuant to the
Plan, shall be final, binding, and conclusive. The validity of any such interpretation, construction, decision or finding of fact
shall not be given de novo review if challenged in court, by arbitration, or in any other forum, and shall be upheld unless clearly
made in bad faith or materially affected by fraud.
(f) No
Liability; Indemnification. Neither the Board nor any Trustee or Committee member, nor any Person acting at the direction
of the Board or the Committee, shall be liable for any act, omission, interpretation, construction, or determination made in good
faith with respect to the Plan, any Award, or any Award Agreement. The Company and its Affiliates shall pay or reimburse any Committee
member, Trustee, Employee, or Consultant who in good faith takes action on behalf of the Plan for all expenses incurred with respect
to the Plan, and to the full extent allowable under Applicable Law shall indemnify each and every one of them for any claims,
liabilities, and costs (including reasonable attorney’s fees) arising out of their good faith performance of duties on behalf
of the Plan. The Company and its Affiliates may, but shall not be required to, obtain liability insurance for this purpose.
(g) Claims
Limitations Period. Any Participant who believes he or she is being denied any benefit or right under this Plan or under any
Award may file a written claim with the Committee. Any claim must be delivered to the Committee within sixty (60) days of
the specific event giving rise to the claim. Untimely claims will not be processed and shall be deemed denied. The Committee will
notify the Participant of its decision in writing as soon as administratively practicable. Claims not responded to by the Committee
in writing within 120 days of the date the written claim is delivered to the Committee shall be deemed denied. The Committee’s
decision, including any deemed denial, is final, binding and conclusive on all persons. No lawsuit relating to this Plan may be
filed before a written claim is filed with the Committee and is denied or deemed denied, and any permitted lawsuit must be filed
within one year of such denial or deemed denial or be forever barred.
(h) Expenses.
The expenses of administering the Plan shall be borne jointly and severally by the Company and its Affiliates.
16. Time
of Granting Awards. The date of grant (“Grant Date”) of an Award shall be the date on which
the Committee makes the determination granting such Award or such other date as is determined by the Committee, provided that
in the case of an ISO, the Grant Date shall be the later of the date on which the Committee makes the determination granting such
ISO or the date of commencement of the Participant’s employment relationship with the Company; and, provide further, that
the grant date under generally accepted accounting principles as consistently applied by the Company may be different than the
Grant Date hereunder.
17. Modification
of Awards and Substitution of Options. Within the limitations of the Plan, the Committee may modify an Award to accelerate
the rate at which an Option or SAR may be exercised, to accelerate the vesting of any Award, to extend or renew outstanding Awards,
to accept the cancellation of outstanding Awards to the extent not previously exercised, or to make any change that the Plan would
permit for a new Award. However, except as approved by the Company’s shareholders for any period during which it is subject
to the reporting requirements of the Exchange Act, any amendment to this Plan or any Award Agreement that results in the repricing
of an Option or SAR issued under this Plan shall not be effective without prior approval of the shareholders of the Company. For
this purpose, repricing includes a reduction in the exercise price of an Option or SAR or the cancellation of an Option or SAR
in exchange for cash, Options, or SARs with an exercise price less than the exercise price of the cancelled Option or SAR, other
awards under this Plan, or any other consideration provided by the Company. Notwithstanding the foregoing in this Section 17,
and except as provided in Section 13, no modification of an outstanding Award may materially and adversely affect a Participant’s
rights thereunder unless either (i) the Participant provides written consent to the modification, or (ii) before a Change
in Control, the Committee determines in good faith that the modification is not materially adverse to the Participant.
18. Plan
Amendment and Termination. The Committee may amend or terminate the Plan as it shall deem advisable; provided that no
change shall be made that increases the total number of Shares reserved for issuance pursuant to Awards (except pursuant to Section 12
above) unless such change is authorized by the shareholders of the Company. A termination or amendment of the Plan shall not materially
and adversely affect a Participant’s vested rights under an Award previously granted to him or her, unless the Participant
consents in writing to such termination or amendment. Notwithstanding the foregoing, the Committee may amend the Plan to comply
with changes in tax, securities laws or regulations, or U.S. generally accepted accounting principles, or in the interpretation
thereof.
19. Term
of Plan. If not sooner terminated by the Board, this Plan shall terminate at the close of business on the date ten (10) years
after the earlier of the date on which the Board approved the Plan and the Effective Date of the Plan as determined under Section 1(b)
above. No Awards shall be made under the Plan after its termination.
20. Governing
Law. The terms of this Plan shall be governed by the laws of the State of Maryland, within the United States of America,
without regard to the State’s conflict of laws rules.
21. Laws
and Regulations.
(a) General
Rules. This Plan, the granting of Awards, the exercise of Options and SARs, and the obligations of the Company hereunder (including
those to pay cash or to deliver, sell, or accept the surrender of any of its Shares or other securities) shall be subject to all
Applicable Law. In the event that any Shares are not registered under any Applicable Law prior to the required delivery of them
pursuant to Awards, the Company may require, as a condition to their issuance or delivery, that the persons to whom the Shares
are to be issued or delivered make any written representations and warranties (such as that such Shares are being acquired by
the Participant for investment for the Participant’s own account and not with a view to, for resale in connection with,
or with an intent of participating directly or indirectly in, any distribution of such Shares) that the Committee may reasonably
require, and the Committee may in its sole discretion include a legend to such effect on the certificates representing any Shares
issued or delivered pursuant to the Plan.
(b) Black-out
Periods. Notwithstanding any contrary terms within the Plan or any Award Agreement, the Committee shall have the absolute
discretion to impose a “blackout” period on the exercise of any Option or SAR, as well as the settlement of any Award,
with respect to any or all Participants (including those whose Continuous Service has ended) to the extent that the Committee
determines that doing so is either desirable or required in order to comply with applicable securities laws.
(c) Severability;
Blue Pencil. In the event that any one or more of the provisions of this Plan shall be or become invalid, illegal or unenforceable
in any respect, the validity, legality and enforceability of the remaining provisions contained herein shall not be affected thereby.
If, in the opinion of any court of competent jurisdiction such covenants are not reasonable in any respect, such court shall have
the right, power and authority to excise or modify such provision or provisions of these covenants as to the court shall appear
not reasonable and to enforce the remainder of these covenants as so amended.
22. No
Shareholder Rights. Neither any Participant nor any transferee or Beneficiary of a Participant shall have any rights as
a shareholder of the Company with respect to any Shares underlying any Award until the date of issuance of a share (by certificate
or book-entry) to such Participant, transferee, or Beneficiary for such Shares in accordance with the Company’s governing
instruments and Applicable Law. Prior to the issuance of Shares or Restricted Shares pursuant to an Award, a Participant shall
not have the right to vote or to receive dividends or any other rights as a shareholder with respect to the Shares underlying
the Award (unless otherwise provided in the Award Agreement for Restricted Shares), notwithstanding its exercise in the case of
Options and SARs. No adjustment will be made for a dividend or other right that is determined based on a record date prior to
the date the stock certificate is issued, except as otherwise specifically provided for in this Plan or an Award Agreement.
23. No
Employment Rights. The Plan shall not confer upon any Participant any right to continue an employment, service or consulting
relationship with the Company, nor shall it affect in any way a Participant’s right or the Company’s right to terminate
the Participant’s employment, service, or consulting relationship at any time, with or without Cause.
24. Data
Privacy. As a condition of receipt of any Award, each Participant explicitly and unambiguously consents to the collection,
use, and transfer, in electronic or other form, of personal data as described in this Section 24 by and among, as applicable,
the Company and its Affiliates for the purpose of implementing, administering, and managing this Plan and Awards and the Participant’s
participation in this Plan. In furtherance of such implementation, administration, and management, the Company and its Affiliates
may hold certain personal information about a Participant, including, but not limited to, the Participant’s name, home address,
telephone number, date of birth, social security or insurance number or other identification number, salary, nationality, job
title(s), information regarding any securities of the Company or any of its Affiliates, and details of all Awards (the “Data”).
In addition to transferring the Data amongst themselves as necessary for the purpose of implementation, administration, and management
of this Plan and Awards and the Participant’s participation in this Plan, the Company and its Affiliates may each transfer
the Data to any third parties assisting the Company in the implementation, administration, and management of this Plan and Awards
and the Participant’s participation in this Plan. Recipients of the Data may be located in the Participant’s country
or elsewhere, and the Participant’s country and any given recipient’s country may have different data privacy laws
and protections. By accepting an Award, each Participant authorizes such recipients to receive, possess, use, retain, and transfer
the Data, in electronic or other form, for the purposes of assisting the Company in the implementation, administration, and management
of this Plan and Awards and the Participant’s participation in this Plan, including any requisite transfer of such Data
as may be required to a broker or other third party with whom the Company or the Participant may elect to deposit any Shares.
The Data related to a Participant will be held only as long as is necessary to implement, administer, and manage this Plan and
Awards and the Participant’s participation in this Plan. A Participant may, at any time, view the Data held by the Company
with respect to such Participant, request additional information about the storage and processing of the Data with respect to
such Participant, recommend any necessary corrections to the Data with respect to the Participant, or refuse or withdraw the consents
herein in writing, in any case without cost, by contacting the Participant’s local human resources representative. The Company
may cancel the Participant’s eligibility to participate in this Plan, and in the Committee’s sole and absolute discretion,
the Participant may forfeit any outstanding Awards if the Participant refuses or withdraws the consents described herein. For
more information on the consequences of refusal to consent or withdrawal of consent, Participants may contact their local human
resources representative.
Appendix I:
Definitions
As
used in the Plan, the following terms have the meanings indicated when they begin with initial capital letters within the Plan:
“Affiliate”
means, with respect to any Person, any other Person that directly or indirectly controls or is controlled by or under common control
with such Person. For the purposes of this definition, “control,” when used with respect to any Person, means the
possession, direct or indirect, of the power to direct or cause the direction of the management and policies of such Person or
the power to elect directors, whether through the ownership of voting securities, by contract, or otherwise, and the terms “affiliated,”
“controlling,” and “controlled” have meanings correlative to the foregoing.
“Applicable
Law” means the legal requirements relating to the administration of options and share-based plans under any applicable
laws of the United States, any other country, and any provincial, state, or local subdivision, any applicable stock exchange or
automated quotation system rules or regulations, as such laws, rules, regulations and requirements shall be in place from time
to time.
“Award”
means any award made, in writing or by an electronic medium, pursuant to the Plan, including awards made in the form of an Option,
a SAR, a Restricted Share, a RSU, an Unrestricted Share, a Performance Award, or Dividend Equivalent Rights, or any combination
thereof, whether alternative or cumulative.
“Award
Agreement” means any written document setting forth the terms of an Award that has been authorized by the Committee.
The Committee shall determine the form or forms of documents to be used and may change them from time to time for any reason.
“Beneficiary”
means the person or entity designated by the Participant, in a form approved by the Company, to exercise the Participant’s
rights with respect to an Award or to receive payment or settlement under an Award after the Participant’s death.
“Board”
means the Board of Trustees of the Company.
“Cause”
for termination of a Participant’s Continuous Service will have the meaning set forth in any unexpired employment agreement
between the Company and the Participant. In the absence of such an agreement, “Cause” will exist if the Participant
is terminated from employment or other service with the Company or any of its Affiliates for any of the following reasons: (i) the
Participant’s willful failure to substantially perform his or her duties and responsibilities to the Company or deliberate
violation of a material Company policy; (ii) the Participant’s commission of any material act or acts of fraud, embezzlement,
dishonesty, or other willful misconduct; (iii) the Participant’s material unauthorized use or disclosure of any proprietary
information or trade secrets of the Company or any other party to whom the Participant owes an obligation of nondisclosure as
a result of his or her relationship with the Company; or (iv) Participant’s willful and material breach of any of his
or her obligations under any written agreement or covenant with the Company.
The
Committee shall in its discretion determine whether or not a Participant is being terminated for Cause. The Committee’s
determination shall, unless arbitrary and capricious, be final and binding on the Participant, the Company, and all other affected
persons. The foregoing definition does not in any way limit the Company’s ability to terminate a Participant’s employment
or consulting relationship at any time, and the term “Company” will be interpreted herein to include any Affiliate
or successor thereto, if appropriate.
“Change
in Control” means any of the following:
(i) Acquisition
of Controlling Interest. Any Person (other than Persons who are Employees at any time more than one year before a transaction)
becomes the beneficial owner, directly or indirectly, of securities of the Company representing 50% or more of the combined
voting power of the
Company’s then outstanding securities. In applying the preceding sentence, (i) securities acquired
directly from the Company or its Affiliates by or for the Person shall not be taken into account, and (ii) an agreement to
vote securities shall be disregarded unless its ultimate purpose is to cause what would otherwise be Change of Control, as reasonably
determined by the Board.
(ii) Change
in Board Control. During a consecutive two (2)-year period commencing after the date of adoption of this Plan, individuals
who constituted the Board at the beginning of the period (or their approved replacements, as defined in the next sentence) cease
for any reason to constitute a majority of the Board. A new Trustee shall be considered an “approved replacement”
Trustee if his or her election (or nomination for election) was approved by a vote of at least a majority of the Trustees then
still in office who either were Trustees at the beginning of the period or were themselves approved replacement Trustees, but
in either case excluding any Trustee whose initial assumption of office occurred as a result of an actual or threatened solicitation
of proxies or consents by or on behalf of any Person other than the Board.
(iii) Merger.
The Company consummates a merger, or consolidation of the Company with any other corporation unless: (a) the voting securities
of the Company outstanding immediately before the merger or consolidation would continue to represent (either by remaining outstanding
or by being converted into voting securities of the surviving entity) at least 50% of the combined voting power
of the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation; and
(b) no Person (other than Persons who are Employees at any time more than one year before a transaction) becomes
the beneficial owner, directly or indirectly, of securities of the Company representing 50% or more of the
combined voting power of the Company’s then outstanding securities.
(iv) Sale
of Assets. The stockholders of the Company approve an agreement for the sale or disposition by the Company of all, or substantially
all, of the Company’s assets.
(v) Liquidation
or Dissolution. The stockholders of the Company approve a plan or proposal for liquidation or dissolution of the Company.
Notwithstanding
the foregoing, a “Change in Control” shall not be deemed to have occurred by virtue of the consummation of any transaction
or series of integrated transactions immediately following which the record holders of the Common Shares immediately prior to
such transaction or series of transactions continue to have substantially the same proportionate ownership in an entity which
owns all or substantially all of the assets of the Company immediately following such transaction or series of transactions.
“Code”
means the Internal Revenue Code of 1986, as amended.
“Committee”
means the Compensation Committee of the Board or its successor, provided that the term “Committee” means (i) the
Board when acting at any time in lieu of the Committee and (ii) with respect to any decision relating to a Reporting Person,
a committee consisting solely of two or more Trustees who are disinterested within the meaning of Rule 16b-3.
“Company”
means LXP Industrial Trust, a Maryland real estate investment trust; provided that in the event the Company reincorporates to
another jurisdiction, all references to the term “Company” shall refer to the Company in such new jurisdiction.
“Company
Share” means a share of beneficial interest, $.0001 par value per share, of the Company classified as “common
stock.” In the event of a change in the capital structure of the Company affecting the common stock (as provided in Section 12),
the Shares resulting from such a change in the common stock shall be deemed to be Company Stock within the meaning of the Plan.
“Consultant”
means any person (other than an Employee or Trustee), including an advisor, who is engaged by the Company or any Affiliate to
render services and is compensated for such services.
“Continuous
Service” means a Participant’s period of service in the absence of any interruption or termination, as an
Employee, Trustee, or Consultant. Continuous Service shall not be considered interrupted in the case of: (i) sick leave;
(ii) military leave; (iii) any other leave of absence approved by the Committee, provided that such leave is for a period
of not more than 90 days, unless reemployment upon the expiration of such leave is guaranteed by contract or statute,
or unless provided otherwise pursuant to Company policy adopted from time to time; (iv) changes in status from Trustee to
advisory director or emeritus status; or (iv) transfers between locations of the Company or between the Company and its Affiliates.
Changes in status between service as an Employee, Trustee, and a Consultant will not constitute an interruption of Continuous
Service if the individual continues to perform bona fide services for the Company. The Committee shall have the discretion to
determine whether and to what extent the vesting of any Awards shall be tolled during any paid or unpaid leave of absence; provided,
however, that in the absence of such determination, vesting for all Awards shall be tolled during any such unpaid leave (but not
for a paid leave).
“Disabled”
will have the meaning set forth in any unexpired employment agreement between the Company and the Participant. In the absence
of such an agreement, “Disabled” means (i) for an ISO, that the Participant is disabled within the meaning of
Code Section 22(e) (3), and (ii) for other Awards, a condition under which that the Participant:
(i) is
unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which
can be expected to result in death or can be expected to last for a continuous period of not less than twelve (12) months;
or
(ii) is,
by reason of any medically determinable physical or mental impairment which can be expected to result in death or can be expected
to last for a continuous period of not less than twelve (12) months, received income replacement benefits for a period of
not less than three months under an accident or health plan covering employees of the Company.
“Dividend
Equivalent Rights” means Awards pursuant to Section 9 of the Plan, which may be attached to other Awards.
“Effective
Date” means the date on which the Company’s shareholders approve the Plan.
“Eligible
Person” means any Consultant, Trustee, or Employee and includes non-Employees to whom an offer of employment has
been or is being extended.
“Employee”
means any person whom the Company or any Affiliate classifies as an employee (including an officer) for employment tax purposes,
whether or not that classification is correct. The payment by the Company of a director’s fee to a Trustee shall not be
sufficient to constitute “employment” of such Trustee by the Company.
“Employer”
means the Company and each Subsidiary and Affiliate that employs one or more Participants.
“Exchange
Act” means the Securities Exchange Act of 1934, as amended.
“Fair
Market Value” means, as of any date (the “Determination Date”) means: (i) the closing
price of a Share on the New York Stock Exchange or the American Stock Exchange (collectively, the “Exchange”),
on the day before (or, with respect to a Grant Date, the day of) Determination Date, or, if shares were not traded on such day,
then on the nearest preceding trading day during which a sale occurred; or (ii) if such stock is not traded on the Exchange
but is quoted on NASDAQ or a successor quotation system, (A) the last sales price (if the stock is then listed as a National
Market Issue under The Nasdaq National Market System) or (B) the mean between the closing representative bid and asked prices
(in all other cases) for the stock on the day before the Determination Date as reported by NASDAQ or such successor quotation
system; or (iii) if such stock is not traded on the Exchange or quoted on NASDAQ but is otherwise traded in the over-the-counter,
the mean between the representative bid and asked prices on the day before the Determination Date; or (iv) if subsections (i)-(iii)
do not apply, the fair market value established in good faith by the Board.
“Grant
Date” has the meaning set forth in Section 16 of the Plan.
“Immediate
Family” means any child, stepchild, grandchild, parent, stepparent, grandparent, spouse, former spouse, sibling,
niece, nephew, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law, and shall include
adoptive relationships.
“Incentive
Stock Option” (or “ISO”) means, an Option that qualifies for favorable income tax treatment
under Code Section 422.
“Involuntary
Termination” means termination of a Participant’s Continuous Service under the following circumstances occurring
on or after a Change in Control:
(i) termination
without Cause by the Company or an Affiliate or successor thereto, as appropriate; or
(ii) voluntary
resignation by the Participant through the following actions: (1) the Participant provides the Company with written notice
of the existence of one of the events, arising without the Participant’s consent, listed in clauses (A) through (C),
below within thirty (30) days of the initial existence of such event; (2) the Company fails to cure such event within
thirty (30) days following the date such notice is given; and (3) the Participant elects to voluntarily terminate employment
within the ninety (90) day period immediately following such event. The events include: (A) a material reduction in
the Participant’s authority, duties, and responsibilities, provided that a mere change in the Participant’s title
shall not trigger an Involuntary Termination, (B) the Participant being required to relocate his place of employment, other
than a relocation within fifty (50) miles of the Participant’s principal work site at the time of the Change in Control,
or (C) a material reduction in the Participant’s Base Salary other than any such reduction consistent with a general
reduction of pay for similarly-situated Participants.
“Non-ISO”
means an Option not intended to qualify as an Incentive Stock Option, as designated in the applicable Award Agreement.
“Option
Proceeds” shall mean the cash actually received by the Company for the exercise price in connection with the exercise
of Options that are exercised after the Effective Date of the Plan, plus the maximum tax benefit that could be realized by the
Company as a result of the exercise of such Options, which tax benefit shall be determined by multiplying (i) the amount
that is deductible for Federal income tax purposes as a result of any such Option exercise (currently, equal to the amount upon
which the Participant’s withholding tax obligation is calculated), times (ii) the maximum Federal corporate income
tax rate for the year of exercise. With respect to Options, to the extent that a Participant pays the exercise price and/or withholding
taxes with Shares, Option Proceeds shall not be calculated with respect to the amounts so paid in Shares
“Option”
means a right to purchase Shares at a price and on terms and conditions determined in accordance with the Plan.
“Participant”
means any Eligible Person who holds an outstanding Award.
“Performance
Awards” mean Awards granted pursuant to Section 8 of the Plan.
“Performance
Criteria” shall mean any quantitative and/or qualitative measures, as determined by the Committee, which may be
used to measure the level of performance of the Company or any individual Participant during a Performance Period.
“Performance
Period” shall mean any period as determined by the Committee in its sole discretion.
“Person”
means any natural person, association, trust, business trust, cooperative, corporation, general partnership, joint venture, joint-
stock company, limited partnership, limited liability company, real estate investment trust, regulatory body, governmental agency
or instrumentality, unincorporated organization or organizational entity.
“Plan”
means this LXP Industrial Trust 2022 Equity-Based Award Plan.
“Recapture”,
“Rescission”, “Reimbursement” have the meanings set forth in Section 13
of the Plan.
“Recoupment”
has the meaning set forth in Section 13 of the Plan.
“Reporting
Person” means an Employee, Trustee, or Consultant who is subject to the reporting requirements set forth under Rule 16b-3.
“Restricted
Share” means a Company Share awarded with restrictions imposed under Section 7.
“Restricted
Share Unit” or “RSU” means a right granted to a Participant to receive Shares or cash
upon the lapse of restrictions imposed under Section 7.
“Retirement”
means a Participant’s termination of employment after age 65.
“Rule 16b-3”
means Rule 16b-3 promulgated under the Exchange Act, as amended from time to time, or any successor provision.
“Share”
means a share of Common Stock of the Company, as adjusted in accordance with Section 13 of the Plan.
“SAR”
or “Share Appreciation Right” means a right to receive amounts awarded under Section 6.
“Ten
Percent Holder” means a person who owns (within the meaning of Code Section 422) stock representing more than
ten percent (10%) of the combined voting power of all classes of stock of the Company.
“Termination”
has the meaning set forth in Section 15 of the Plan.
“Trustee”
means a member of the Board, or a member of the board of directors of an Affiliate of the Company.
“Unrestricted
Shares” mean Shares that are not subject to restrictions that are awarded pursuant to Section 7 of the Plan.
“Withholding
Taxes” means the aggregate amount, up to maximum statutory limits as in effect from time to time, of federal, state,
local and foreign income, payroll and other taxes that the Company and any of its Affiliates are required to withhold in connection
with any Award.
YOUR VOTE IS IMPORTANT!
SEE REVERSE SIDE FOR FOUR EASY WAYS TO VOTE VIA THE INTERNET, BY TELEPHONE OR BY MAIL
YOU MAY VOTE VIA THE INTERNET OR BY TELEPHONE. YOUR INTERNET OR TELEPHONE VOTE MUST BE
RECEIVED BY 11:59 P.M. EASTERN DAYLIGHT TIME ON MAY 23, 2022. IF YOU DO NOT VOTE VIA THE INTERNET OR
TELEPHONE, THEN PLEASE MARK, SIGN, DATE AND RETURN THIS WHITE PROXY CARD PROMPTLY. YOUR MAIL
VOTE MUST BE RECEIVED IN SUFFICIENT TIME BEFORE THE ANNUAL MEETING.
If you have any questions, would like to request additional copies of proxy materials
or need assistance voting your WHITE proxy card, please contact LXP Industrial Trust’s proxy solicitor:
D.F. King & Co., Inc.
48 Wall Street, 22nd Floor
New York, New York 10005
Banks and Brokers Call Collect: (212) 269-5550All Others Call Toll-Free: (866) 811-1442
Email: LXP@dfking.com
•
Please sign and date the WHITE proxy card below and fold and detach at the perforation before mailing. •
LXP INDUSTRIAL TRUST WHITE PROXY CARD
Proxy Solicited by Board of Trustees for 2022 Annual Meeting of Shareholders — May 24, 2022
The undersigned shareholder of LXP Industrial Trust, a Maryland real estate investment trust, hereby
appoints Beth Boulerice and Joseph S. Bonventre, or either of them as proxies (“Proxies”) for the
undersigned, each with the power of substitution, to attend the 2022 Annual Meeting of Shareholders of
LXP Industrial Trust to be held on May 24, 2022, at 10:00 a.m., Eastern Time, virtually via the internet at
www.cesonlineservices.com/lxp22_vm, or any postponement or adjournment thereof, to cast on behalf of
the undersigned all votes that the undersigned is entitled to cast at such meeting and otherwise to
represent the undersigned at the meeting with all powers possessed by the undersigned if personally
present at the meeting. The undersigned hereby acknowledges receipt of the Notice of 2022 Annual
Meeting of Shareholders and of the accompanying proxy statement, the terms of each of which are
incorporated by reference, and revokes any proxy heretofore given with respect to such meeting.
Shares represented by this proxy will be voted as instructed on the reverse side. If no such instructions are
indicated, but this proxy is properly executed, the Proxies will have authority to vote FOR the election of
each of the nominees listed in Proposal 1 and FOR Proposals 2, 3, 4 and 5.
In their discretion, the Proxies are authorized to vote upon such other business as may properly come
before the meeting or any postponement or adjournment thereof.
(Items to be voted appear on reverse side)
LXP INDUSTRIAL TRUST
c/o Corporate Election Services
P.O. Box 3230
Pittsburgh, PA 15230 ANNUAL MEETING OF SHAREHOLDERS
MAY 24, 2022
YOUR VOTE IS IMPORTANT
Please take a moment now to vote your shares of
LXP Industrial Trust for the 2022 annual meeting
of shareholders.
YOU CAN VOTE TODAY IN ONE OF FOUR WAYS:
Your vote is important! Even if you plan to attend our virtual annual meeting, please cast your vote as soon as possible by:
Internet QR Code Telephone Mail
Access the Internet site and
cast your vote: OR
OR
Call Toll-Free:
ORReturn your WHITE proxy
card in the postage-paid
www.cesvote.com 1-888-693-8683 envelope provided
Your Internet or telephone vote must be received by 11:59 p.m. Eastern Daylight Time on May 23, 2022.
Scan with a mobile device
Control Number •
•
Please sign and date the WHITE proxy card below and fold and detach at the perforation before mailing. •
When properly executed, your WHITE proxy card will be voted in the manner you direct. If you do not specify your choices, yourshares will be voted FOR each of the nominees listed in Proposal 1, and FOR Proposals 2, 3, 4 and 5.
The Board of Trustees unanimously recommends a vote The Board of Trustees unanimously recommends a vote FOR
FOR each of the nominees listed in Proposal 1. Proposals 2, 3, 4 and 5.
1.
Election of Trustees: FOR WITHHOLD FOR ALL 2. To consider and vote upon an advisory, non-binding resolution to approve
ALL ALL EXCEPT the compensation of the named executive officers, as disclosed in the
(1) T. Wilson Eglin
accompanying proxy statement.
..
.
(2) Richard S. Frary
.
FOR . AGAINST .
ABSTAIN
(3) Lawrence L. Gray
To withhold authority to vote for any
3.
To consider and vote upon an amendment to our Declaration of Trust to
(4)
Arun Gupta individual nominee(s), mark “For All
Except” and write the number(s) of the
increase the number of authorized shares of beneficial interest.
(5) Jamie Handwerker
nominees in the space below.
.
FOR . AGAINST .
ABSTAIN
(6) Claire A. Koeneman
4.
To consider and vote upon a proposal to approve the LXP Industrial Trust
(7) Nancy Elizabeth Noe
2022 Equity-Based Award Plan.
(8) Howard Roth
.
FOR . AGAINST .
ABSTAIN
5.
To consider and vote upon the ratification of the appointment of
Deloitte & Touche LLP as our independent registered public accounting firm
for the fiscal year ending December 31, 2022.
.
FOR . AGAINST .
ABSTAIN
Signature
Date
Signature (Joint Tenant) Date
INSTRUCTIONS: Please sign exactly as your name(s) appears(s) on this proxy card. When
signing as an attorney, executor, administrator, trustee, guardian or other fiduciary please give full
title as such. Joint owners should each sign personally. All holders must sign. If a corporation or
partnership, please sign in full corporate or partnership name, by authorized officer.